US9504590B2 - Stent retained on a balloon catheter - Google Patents
- ️Tue Nov 29 2016
US9504590B2 - Stent retained on a balloon catheter - Google Patents
Stent retained on a balloon catheter Download PDFInfo
-
Publication number
- US9504590B2 US9504590B2 US14/059,382 US201314059382A US9504590B2 US 9504590 B2 US9504590 B2 US 9504590B2 US 201314059382 A US201314059382 A US 201314059382A US 9504590 B2 US9504590 B2 US 9504590B2 Authority
- US
- United States Prior art keywords
- balloon
- stent
- crimping
- inflated
- prearranged Prior art date
- 2007-09-28 Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active, expires 2028-04-12
Links
- 230000000717 retained effect Effects 0.000 title description 2
- 238000002788 crimping Methods 0.000 claims description 93
- 238000000034 method Methods 0.000 claims description 67
- 239000000463 material Substances 0.000 claims description 31
- 229920000642 polymer Polymers 0.000 claims description 21
- 239000012530 fluid Substances 0.000 claims description 13
- 230000001788 irregular Effects 0.000 claims description 10
- 239000012528 membrane Substances 0.000 claims description 7
- 230000009477 glass transition Effects 0.000 claims description 5
- 229920001432 poly(L-lactide) Polymers 0.000 claims description 2
- -1 stainless steel Chemical class 0.000 description 28
- 239000011248 coating agent Substances 0.000 description 18
- 238000000576 coating method Methods 0.000 description 18
- 230000008569 process Effects 0.000 description 16
- 229910052751 metal Inorganic materials 0.000 description 13
- 239000002184 metal Substances 0.000 description 13
- 230000014759 maintenance of location Effects 0.000 description 11
- 238000012360 testing method Methods 0.000 description 8
- 238000011068 loading method Methods 0.000 description 7
- PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 description 6
- 230000002829 reductive effect Effects 0.000 description 6
- 230000035882 stress Effects 0.000 description 6
- 230000037303 wrinkles Effects 0.000 description 5
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 4
- 230000006378 damage Effects 0.000 description 4
- 229940079593 drug Drugs 0.000 description 4
- 239000003814 drug Substances 0.000 description 4
- 238000012545 processing Methods 0.000 description 4
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 description 3
- ZOKXTWBITQBERF-UHFFFAOYSA-N Molybdenum Chemical compound [Mo] ZOKXTWBITQBERF-UHFFFAOYSA-N 0.000 description 3
- 239000000853 adhesive Substances 0.000 description 3
- 230000001070 adhesive effect Effects 0.000 description 3
- 230000032683 aging Effects 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 229920001400 block copolymer Polymers 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 239000011651 chromium Substances 0.000 description 3
- 238000013461 design Methods 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 239000007769 metal material Substances 0.000 description 3
- 239000011733 molybdenum Substances 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- 229920000219 Ethylene vinyl alcohol Polymers 0.000 description 2
- 239000002033 PVDF binder Substances 0.000 description 2
- 229920001244 Poly(D,L-lactide) Polymers 0.000 description 2
- 239000002202 Polyethylene glycol Substances 0.000 description 2
- 208000027418 Wounds and injury Diseases 0.000 description 2
- 230000002411 adverse Effects 0.000 description 2
- 238000002399 angioplasty Methods 0.000 description 2
- 238000013459 approach Methods 0.000 description 2
- 238000005452 bending Methods 0.000 description 2
- 229920002988 biodegradable polymer Polymers 0.000 description 2
- 239000004621 biodegradable polymer Substances 0.000 description 2
- 229920002678 cellulose Polymers 0.000 description 2
- 239000001913 cellulose Substances 0.000 description 2
- 229910052804 chromium Inorganic materials 0.000 description 2
- 229910017052 cobalt Inorganic materials 0.000 description 2
- 239000010941 cobalt Substances 0.000 description 2
- GUTLYIVDDKVIGB-UHFFFAOYSA-N cobalt atom Chemical compound [Co] GUTLYIVDDKVIGB-UHFFFAOYSA-N 0.000 description 2
- 230000006835 compression Effects 0.000 description 2
- 238000007906 compression Methods 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 238000002844 melting Methods 0.000 description 2
- 230000008018 melting Effects 0.000 description 2
- 229910052750 molybdenum Inorganic materials 0.000 description 2
- 229910052759 nickel Inorganic materials 0.000 description 2
- 230000003287 optical effect Effects 0.000 description 2
- 229920000747 poly(lactic acid) Polymers 0.000 description 2
- 229920000058 polyacrylate Polymers 0.000 description 2
- 229920002635 polyurethane Polymers 0.000 description 2
- 239000004814 polyurethane Substances 0.000 description 2
- 229920002981 polyvinylidene fluoride Polymers 0.000 description 2
- 238000003908 quality control method Methods 0.000 description 2
- 239000010935 stainless steel Substances 0.000 description 2
- 229910001220 stainless steel Inorganic materials 0.000 description 2
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 1
- BQCIDUSAKPWEOX-UHFFFAOYSA-N 1,1-Difluoroethene Chemical compound FC(F)=C BQCIDUSAKPWEOX-UHFFFAOYSA-N 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- 229920000298 Cellophane Polymers 0.000 description 1
- DQEFEBPAPFSJLV-UHFFFAOYSA-N Cellulose propionate Chemical compound CCC(=O)OCC1OC(OC(=O)CC)C(OC(=O)CC)C(OC(=O)CC)C1OC1C(OC(=O)CC)C(OC(=O)CC)C(OC(=O)CC)C(COC(=O)CC)O1 DQEFEBPAPFSJLV-UHFFFAOYSA-N 0.000 description 1
- 229920002101 Chitin Polymers 0.000 description 1
- 229920001661 Chitosan Polymers 0.000 description 1
- 229910000531 Co alloy Inorganic materials 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 229910000599 Cr alloy Inorganic materials 0.000 description 1
- 102000009123 Fibrin Human genes 0.000 description 1
- 108010073385 Fibrin Proteins 0.000 description 1
- BWGVNKXGVNDBDI-UHFFFAOYSA-N Fibrin monomer Chemical compound CNC(=O)CNC(=O)CN BWGVNKXGVNDBDI-UHFFFAOYSA-N 0.000 description 1
- 102000008946 Fibrinogen Human genes 0.000 description 1
- 108010049003 Fibrinogen Proteins 0.000 description 1
- 229920006370 Kynar Polymers 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 229910001182 Mo alloy Inorganic materials 0.000 description 1
- 229910000990 Ni alloy Inorganic materials 0.000 description 1
- 239000000020 Nitrocellulose Substances 0.000 description 1
- 229920002292 Nylon 6 Polymers 0.000 description 1
- 229920002302 Nylon 6,6 Polymers 0.000 description 1
- 208000031481 Pathologic Constriction Diseases 0.000 description 1
- 229910000566 Platinum-iridium alloy Inorganic materials 0.000 description 1
- 229920001077 Poly(N-acetyl glucosamine) Polymers 0.000 description 1
- 239000004952 Polyamide Substances 0.000 description 1
- 229920002732 Polyanhydride Polymers 0.000 description 1
- 229920000954 Polyglycolide Polymers 0.000 description 1
- 229920000331 Polyhydroxybutyrate Polymers 0.000 description 1
- 239000004642 Polyimide Substances 0.000 description 1
- 229920002367 Polyisobutene Polymers 0.000 description 1
- 229920001710 Polyorthoester Polymers 0.000 description 1
- 239000004793 Polystyrene Substances 0.000 description 1
- 229920001328 Polyvinylidene chloride Polymers 0.000 description 1
- 229920000297 Rayon Polymers 0.000 description 1
- 229920006220 SOLEF 21508 PVDF Polymers 0.000 description 1
- 239000004902 Softening Agent Substances 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 229910000831 Steel Inorganic materials 0.000 description 1
- FJWGYAHXMCUOOM-QHOUIDNNSA-N [(2s,3r,4s,5r,6r)-2-[(2r,3r,4s,5r,6s)-4,5-dinitrooxy-2-(nitrooxymethyl)-6-[(2r,3r,4s,5r,6s)-4,5,6-trinitrooxy-2-(nitrooxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-3,5-dinitrooxy-6-(nitrooxymethyl)oxan-4-yl] nitrate Chemical compound O([C@@H]1O[C@@H]([C@H]([C@H](O[N+]([O-])=O)[C@H]1O[N+]([O-])=O)O[C@H]1[C@@H]([C@@H](O[N+]([O-])=O)[C@H](O[N+]([O-])=O)[C@@H](CO[N+]([O-])=O)O1)O[N+]([O-])=O)CO[N+](=O)[O-])[C@@H]1[C@@H](CO[N+]([O-])=O)O[C@@H](O[N+]([O-])=O)[C@H](O[N+]([O-])=O)[C@H]1O[N+]([O-])=O FJWGYAHXMCUOOM-QHOUIDNNSA-N 0.000 description 1
- 238000005299 abrasion Methods 0.000 description 1
- 229920006243 acrylic copolymer Polymers 0.000 description 1
- 229920000122 acrylonitrile butadiene styrene Polymers 0.000 description 1
- 229920001893 acrylonitrile styrene Polymers 0.000 description 1
- 229910045601 alloy Inorganic materials 0.000 description 1
- 239000000956 alloy Substances 0.000 description 1
- 239000012298 atmosphere Substances 0.000 description 1
- 230000006399 behavior Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000036760 body temperature Effects 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 229920002301 cellulose acetate Polymers 0.000 description 1
- 229920006217 cellulose acetate butyrate Polymers 0.000 description 1
- 229920001727 cellulose butyrate Polymers 0.000 description 1
- 229920003086 cellulose ether Polymers 0.000 description 1
- 229920006218 cellulose propionate Polymers 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 229920006212 co-poly(ether-esters) Polymers 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 230000001010 compromised effect Effects 0.000 description 1
- 238000013270 controlled release Methods 0.000 description 1
- 229920001577 copolymer Polymers 0.000 description 1
- 238000007887 coronary angioplasty Methods 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 229920000359 diblock copolymer Polymers 0.000 description 1
- 238000012377 drug delivery Methods 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- UFRKOOWSQGXVKV-UHFFFAOYSA-N ethene;ethenol Chemical compound C=C.OC=C UFRKOOWSQGXVKV-UHFFFAOYSA-N 0.000 description 1
- 239000004715 ethylene vinyl alcohol Substances 0.000 description 1
- 229920006213 ethylene-alphaolefin copolymer Polymers 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 229950003499 fibrin Drugs 0.000 description 1
- 229940012952 fibrinogen Drugs 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 229920000578 graft copolymer Polymers 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 229920002674 hyaluronan Polymers 0.000 description 1
- 229960003160 hyaluronic acid Drugs 0.000 description 1
- 239000007943 implant Substances 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 229910001092 metal group alloy Inorganic materials 0.000 description 1
- 150000002739 metals Chemical class 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 229910001000 nickel titanium Inorganic materials 0.000 description 1
- 229920001220 nitrocellulos Polymers 0.000 description 1
- 230000036961 partial effect Effects 0.000 description 1
- 238000011056 performance test Methods 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- HWLDNSXPUQTBOD-UHFFFAOYSA-N platinum-iridium alloy Chemical class [Ir].[Pt] HWLDNSXPUQTBOD-UHFFFAOYSA-N 0.000 description 1
- 229920001490 poly(butyl methacrylate) polymer Polymers 0.000 description 1
- 229920001200 poly(ethylene-vinyl acetate) Polymers 0.000 description 1
- 229920006211 poly(glycolic acid-co-trimethylene carbonate) Polymers 0.000 description 1
- 239000005015 poly(hydroxybutyrate) Substances 0.000 description 1
- 229920001849 poly(hydroxybutyrate-co-valerate) Polymers 0.000 description 1
- 229920000218 poly(hydroxyvalerate) Polymers 0.000 description 1
- 229920001606 poly(lactic acid-co-glycolic acid) Polymers 0.000 description 1
- 239000002745 poly(ortho ester) Substances 0.000 description 1
- 229920002627 poly(phosphazenes) Polymers 0.000 description 1
- 229920002432 poly(vinyl methyl ether) polymer Polymers 0.000 description 1
- 229920002239 polyacrylonitrile Polymers 0.000 description 1
- 229920002647 polyamide Polymers 0.000 description 1
- 229920001610 polycaprolactone Polymers 0.000 description 1
- 239000004417 polycarbonate Substances 0.000 description 1
- 229920000515 polycarbonate Polymers 0.000 description 1
- 229920000728 polyester Polymers 0.000 description 1
- 229920006149 polyester-amide block copolymer Polymers 0.000 description 1
- 229920000570 polyether Polymers 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 229920001721 polyimide Polymers 0.000 description 1
- 229920000098 polyolefin Polymers 0.000 description 1
- 229920006324 polyoxymethylene Polymers 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 229920002223 polystyrene Polymers 0.000 description 1
- 229920000166 polytrimethylene carbonate Polymers 0.000 description 1
- 229920002689 polyvinyl acetate Polymers 0.000 description 1
- 239000011118 polyvinyl acetate Substances 0.000 description 1
- 229920006216 polyvinyl aromatic Polymers 0.000 description 1
- 239000004800 polyvinyl chloride Substances 0.000 description 1
- 229920000915 polyvinyl chloride Polymers 0.000 description 1
- 229920001290 polyvinyl ester Polymers 0.000 description 1
- 229920001289 polyvinyl ether Polymers 0.000 description 1
- 229920006215 polyvinyl ketone Polymers 0.000 description 1
- 229920000131 polyvinylidene Polymers 0.000 description 1
- 239000005033 polyvinylidene chloride Substances 0.000 description 1
- 229920006214 polyvinylidene halide Polymers 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- SCUZVMOVTVSBLE-UHFFFAOYSA-N prop-2-enenitrile;styrene Chemical compound C=CC#N.C=CC1=CC=CC=C1 SCUZVMOVTVSBLE-UHFFFAOYSA-N 0.000 description 1
- 239000011253 protective coating Substances 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 239000002964 rayon Substances 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 230000036262 stenosis Effects 0.000 description 1
- 208000037804 stenosis Diseases 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 229910052715 tantalum Inorganic materials 0.000 description 1
- GUVRBAGPIYLISA-UHFFFAOYSA-N tantalum atom Chemical compound [Ta] GUVRBAGPIYLISA-UHFFFAOYSA-N 0.000 description 1
- 230000008733 trauma Effects 0.000 description 1
- 229920000428 triblock copolymer Polymers 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 210000005166 vasculature Anatomy 0.000 description 1
- 229920002554 vinyl polymer Polymers 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/95—Instruments specially adapted for placement or removal of stents or stent-grafts
- A61F2/958—Inflatable balloons for placing stents or stent-grafts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/95—Instruments specially adapted for placement or removal of stents or stent-grafts
- A61F2/9522—Means for mounting a stent or stent-graft onto or into a placement instrument
-
- A61F2002/9522—
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B23—MACHINE TOOLS; METAL-WORKING NOT OTHERWISE PROVIDED FOR
- B23P—METAL-WORKING NOT OTHERWISE PROVIDED FOR; COMBINED OPERATIONS; UNIVERSAL MACHINE TOOLS
- B23P11/00—Connecting or disconnecting metal parts or objects by metal-working techniques not otherwise provided for
- B23P11/005—Connecting or disconnecting metal parts or objects by metal-working techniques not otherwise provided for by expanding or crimping
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T29/00—Metal working
- Y10T29/49—Method of mechanical manufacture
- Y10T29/49826—Assembling or joining
- Y10T29/49863—Assembling or joining with prestressing of part
- Y10T29/49865—Assembling or joining with prestressing of part by temperature differential [e.g., shrink fit]
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T29/00—Metal working
- Y10T29/49—Method of mechanical manufacture
- Y10T29/49826—Assembling or joining
- Y10T29/49908—Joining by deforming
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T29/00—Metal working
- Y10T29/49—Method of mechanical manufacture
- Y10T29/49826—Assembling or joining
- Y10T29/49908—Joining by deforming
- Y10T29/49909—Securing cup or tube between axially extending concentric annuli
- Y10T29/49911—Securing cup or tube between axially extending concentric annuli by expanding inner annulus
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T29/00—Metal working
- Y10T29/49—Method of mechanical manufacture
- Y10T29/49826—Assembling or joining
- Y10T29/49908—Joining by deforming
- Y10T29/49909—Securing cup or tube between axially extending concentric annuli
- Y10T29/49913—Securing cup or tube between axially extending concentric annuli by constricting outer annulus
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T29/00—Metal working
- Y10T29/49—Method of mechanical manufacture
- Y10T29/49826—Assembling or joining
- Y10T29/49908—Joining by deforming
- Y10T29/49925—Inward deformation of aperture or hollow body wall
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T29/00—Metal working
- Y10T29/49—Method of mechanical manufacture
- Y10T29/49826—Assembling or joining
- Y10T29/49908—Joining by deforming
- Y10T29/49925—Inward deformation of aperture or hollow body wall
- Y10T29/49934—Inward deformation of aperture or hollow body wall by axially applying force
Definitions
- This invention relates to methods of crimping a stent on a balloon, and a stent secured to a catheter assembly.
- a stent as illustrated in FIG. 1 , is an intravascular prosthesis that is delivered and implanted within a patient's vasculature or other bodily cavities and lumens by a balloon catheter.
- the structure of a stent is typically composed of scaffolding, substrate, or base material that includes a pattern or network of interconnecting structural elements often referred to in the art as struts or bar arms.
- struts or bar arms.
- Stent 14 can include a plurality of struts 16 connected by linking struts 11 , with interstitial spaces 18 located in between the struts.
- the plurality of struts 16 can be configured in an annular fashion in discrete “rows” such that they form a series of “rings” throughout the body of stent 14 .
- Stents can be used in percutaneous transluminal coronary angioplasty (PTCA) or percutaneous transluminal angioplasty (PTA).
- PTCA percutaneous transluminal coronary angioplasty
- PTA percutaneous transluminal angioplasty
- Conventional stents and catheters are disclosed by U.S. Pat. Nos. 4,733,665, 4,800,882, 4,886,062, 5,514,154, 5,569,295, and 5,507,768.
- the stent In advancing a stent through a body vessel to a deployment site, the stent must be able to securely maintain its axial as well as rotational position on the delivery catheter without translocating proximally or distally, and especially without becoming separated from the catheter. Stents that are not properly secured or retained to the catheter may slip and either be lost or be deployed in the wrong location.
- the stent must be “crimped” in such a way as to minimize or prevent distortion of the stent and to thereby prevent abrasion and/or reduce trauma to the vessel walls.
- stent crimping is the act of affixing the stent to the delivery catheter or delivery balloon so that it remains affixed to the catheter or balloon until the physician desires to deliver the stent at the treatment site.
- Current stent crimping technology is sophisticated. Examples of such technology which are known by one of ordinary skill in the art include a roll crimper; a collet crimper; and an iris or sliding-wedge crimper.
- a roll crimper To use a roll crimper, first the stent is slid loosely onto the balloon portion of the catheter. This assembly is placed between the plates of the roll crimper. With an automated roll crimper, the plates come together and apply a specified amount of force.
- the collet crimper is equally conceptually simple.
- a standard drill-chuck collet is equipped with several pie-piece-shaped jaws. These jaws move in a radial direction as an outer ring is turned.
- a stent is loosely placed onto the balloon portion of a catheter and inserted in the center space between the jaws. Turning the outer ring causes the jaws to move inward.
- An issue with this device is determining or designing the crimping endpoint.
- One scheme is to engineer the jaws so that when they completely close, they touch and a center hole of a known diameter remains. Using this approach, turning the collet until the jaws abut each other crimps the stent to the known outer diameter.
- Stent struts have a tolerance on their thickness. Additionally, the process of folding non-compliant balloons is not exactly reproducible. Consequently, the collet crimper exerts a different amount of force on each stent in order to achieve the same final dimension. Unless this force, and the final crimped diameter, is carefully chosen, the variability of the stent and balloon dimensions can yield stent or balloon damage.
- the sliding wedge or iris crimper In the sliding wedge or iris crimper, adjacent pie-piece-shaped sections move inward and twist, much like the leaves in a camera aperture.
- This crimper can be engineered to have two different types of endpoints. It can stop at a final diameter, or it can apply a fixed force and allow the final diameter to float. From the discussion on the collet crimper, there are advantages in applying a fixed level of force as variability in strut and balloon dimension will not change the crimping force.
- the sliding wedges impart primarily normal forces. As the wedges slide over each other, they impart some tangential force.
- the sliding wedge crimper presents a nearly cylindrical inner surface to the stent, even as it crimps. This means the crimping loads are distributed over the entire outer surface of the stent.
- Polymeric stents can also be more susceptible to crack propagation during crimping or expansion by a balloon.
- the load on the struts can vary significantly.
- a significant cause for this load variation is the balloon surface, which due to its variation in surface geometry and stiffness properties over the surface imposes non-uniform reaction forces to crimping against the stent luminal surface.
- the balloon surface is generally not smooth.
- bumps or mounds over the balloon surface can produce different loadings across the stent body.
- a stent is crimped on a non-compliant balloon having folded wings or pleats
- the stiffness in these areas i.e., where the balloon material is folded over itself, can be noticeable higher than in areas distal from the folds.
- Variations in the surface geometry of the balloon and/or stiffness about the circumference and/or length of the balloon can lead to high stress concentrations resulting in twisting, bending, warping of individual struts or segments of the stent.
- the present invention provides a novel method of crimping a stent, more specifically a polymeric stent on an expandable member or a balloon, and a novel apparatus for delivery of a stent on a balloon catheter.
- a method of crimping a stent on a balloon of a catheter assembly includes inflating a balloon, deflating the balloon, disposing the stent over the balloon after deflating the balloon, and then crimping the stent to the balloon.
- the balloon may be inflated to an intermediate pressure, maximum pressure, or hyper-inflated pressure for the balloon before being deflated.
- Various crimping procedures known in the art may be used.
- the crimping procedure may include a step in which the balloon is re-inflated when the stent is disposed over the balloon.
- the deflating step may deflate the balloon to about atmospheric pressure.
- the act of inflating the balloon inflates a balloon configured in a collapsed configuration, such that the balloon has prearranged folds that are heat set.
- the balloon When the balloon is inflated, the heat set folds are removed, or substantially removed from the balloon.
- the balloon When the balloon is deflated, the balloon may partially reform the folds.
- a method of crimping a stent to a balloon includes the steps of inflating the balloon from an initial diameter to a final diameter, deflating the balloon such that the balloon forms a relaxed state, and after deflating the balloon, crimping the stent to the balloon.
- the balloon pressure is reduced to about atmospheric when the balloon is in the relaxed state.
- a balloon catheter includes a balloon of the type having a membrane predisposed to form at least one prearranged fold when in a collapsed configuration, the balloon being configured in a compressed configuration such that the at least one prearranged fold is replaced by at least one irregular fold in the compressed configuration, and a stent secured to the balloon.
- a balloon catheter includes a balloon of the type configured to have at least one prearranged fold when in a collapsed configuration, and a stent compressed onto the balloon such that the balloon is devoid of the at least one prearranged fold.
- the balloon is a non-compliant balloon.
- the balloon has a plurality of prearranged folds when configured in a collapsed configuration, and when the stent is compressed onto the balloon the plurality of folds are replaced by folds resulting from the compression of the stent onto the balloon.
- embodiments of a method and apparatus are disclosed that can reduce the instances of failed or bent stent struts during crimping and/or subsequent expansion of the stent by a balloon catheter.
- the disclosure provides a method and apparatus to improve stent retention and uniform expansion of the stent.
- the disclosure provides a method and apparatus for an improved manufacturing procedure, such as elimination of time consuming steps and improved quality control when stents are secured to a balloon.
- FIG. 1 is a perspective view of a stent
- FIGS. 2A, 2B, 2C and 2D illustrate crimped stents that have struts misaligned by a crimping process.
- FIGS. 4A and 4B show side and axial views, respectively, of the balloon when inflated.
- FIG. 5 illustrates the balloon in FIG. 4A after having being deflated
- FIG. 6 illustrates a side view of the balloon of FIG. 5 with a stent disposed over the balloon
- FIGS. 9A and 9B illustrate an alternative crimping procedure.
- FIG. 2B shows a similar situation for the struts of ring 19 b , also located at the end. Additionally, it can be seen in the stent of FIG. 2B that the rings adjacent ring 19 b are twisted upward. In FIG. 4C it can be seen that an entire row of struts 19 c are twisted upwards or downwards. As mentioned above, it is preferred by design that all struts for this stent extend parallel to the stent longitudinal axis when the stent is crimped to the balloon.
- FIG. 2D shows a similar undesired deformity for ring 19 d . Additionally, ring 19 e located closer to the center of the stent in FIG. 2D also has an desired twist in its struts.
- Polymer stents can require wider struts than metal stents so as to provide suitable mechanical properties, such as radial strength, for the stent.
- suitable mechanical properties such as radial strength
- less space is provided between the struts which can result in worse stent retention than a metallic stent.
- the use of high processing temperature during the crimping process to enhance stent retention may not be possible as a polymeric stent may have a glass transition temperature close to body temperature. Higher processing temperatures may cause the polymeric stent to lose some of its preferred mechanical properties.
- stents can shift on a balloon during a crimping process. For example, if the balloon is inflated while the stent is disposed over the balloon in a crimping machine, the stent longitudinal axis can become skewed from the balloon longitudinal axis, or the stent can shift axially. If this should occur, the stent and balloon will need to be removed from the crimping machine, the stent re-centered and the crimping protocol re-started. It is believed that this misalignment is usually due to non-uniform expansion characteristics of folded balloons. For example, some wings or pleats of a folded balloon may unfold faster than others.
- FIGS. 3A and 3B show side and cross-sectional views of an expandable member, such as a balloon 10 , integrated at a distal end of a catheter assembly 12 .
- the catheter 12 includes a valve 24 to relieve balloon pressure and a pressure source (not shown).
- the balloon 10 is intended to include any type of enclosed member such as an elastic type member that is selectively inflatable to dilate from a collapsed configuration to a desired and controlled expanded configuration.
- the balloon 10 should also be capable of being deflated to a reduced profile or back to its original collapsed configuration.
- the balloon 10 can be made from any suitable type of material and can be of any thickness so long as the ability to crimp the stent onto the balloon and optimum performance capabilities of the balloon are not adversely compromised.
- the balloon is illustrated in FIG. 3A in a collapsed configuration.
- the collapsed configuration can be the configuration that is conventionally used during the process of crimping of a stent on a balloon.
- the balloon 10 includes no liquid or gas in the internal chamber of the balloon 10 .
- Such collapsed configuration can be the configuration of introduction and navigation of the balloon 10 in the vascular system of a patient and may be referred to as a configuration of the balloon in which the balloon has a minimum profile.
- the diameter 10 a of the balloon 10 is then the minimum diameter for the balloon.
- the balloon can be folded when in the collapsed configuration, which is the typical case for collapsed non-compliant balloons.
- Methods according to some embodiments of the invention can include an inflation of the balloon from a collapsed configuration to an inflated state, a deflation of the balloon from the inflated state, and then crimping the stent to the balloon using any known crimping procedure, provided those procedures are not inconsistent with the disclosure.
- the suitable choices for the crimping device and/or procedure that may be used in connection with embodiments of the invention will be understood from the disclosure.
- the crimping, inflation and deflation aspects of the disclosure may each include additional steps or processes, some of which are disclosed herein while others would be readily apparent based on the disclosure.
- a method for securing a stent to a balloon begins with inflation of the balloon 10 to an inflated state, as shown in FIG. 4A .
- the balloon 10 has an inflated diameter 10 b .
- all balloon folds are removed, substantially all balloon folds are removed, the balloon is fully unfolded or the balloon is substantially fully unfolded in the inflated state.
- the balloon takes its final expanded shape, e.g., cylindrical, or substantially its final expanded shape, when the balloon is in the inflated state.
- the inflated shape may also be understood in terms of the internal balloon pressure when the balloon is in the inflated state, instead of the balloon shape.
- the balloon 10 is inflated by a pressure source (not shown) connected to the proximal end of the catheter 12 in FIG. 4A .
- the inflated state may be achieved after the balloon is inflated to a maximum intended pressure or design pressure, an intermediate pressure, a hyper-inflated pressure.
- a balloon inflated to any pressure that causes the balloon to at least partially expand places the balloon in an inflated state.
- Such embodiments include those in which the pressure is sufficient to break any friction between folded wings in the balloon material.
- a maximum intended pressure refers to a balloon pressure considered the highest from a standpoint of acceptable risk of damage to the balloon as prescribed under a standard medical protocol.
- the maximum intended pressure may also refer to the diameter of the balloon when fully expanded, e.g., diameter 10 b in FIG. 4A . In the case of non-compliant balloon this would correspond to the outer balloon diameter after the wings have been fully unfolded.
- the maximum intended pressure may also refer to the balloon pressure that produces approximately the largest diameter designated for clinical use, in the case of compliant or semi-compliant balloons.
- An intermediate pressure refers to a pressure that, while not reaching the maximum intended pressure, is sufficient to substantially remove the folds or kinks in the balloon material when the balloon was in the collapsed configuration, or places the balloon in a substantially unfolded configuration.
- an intermediate pressure for the balloon 10 would be the pressure sufficient to substantially undo the kinks 11 a and 11 b caused by the folded, collapsed configuration in FIG. 3B , but less than the maximum intended pressure for balloon 10 .
- FIG. 4B depicts the balloon 10 when inflated to an intermediate pressure.
- FIG. 4B is one example of a balloon were the folds are substantially removed.
- the places on the balloon material where the balloon material was folded over itself, i.e., kinks or folds 11 a , 11 b cannot be identified.
- the balloon has taken an essentially circular shape.
- a softening agent can be applied to the balloon surface before, during or after the inflated state has been reached. This can make the balloon surface softer or more pliable and can also help to work-out some of the shape memory properties of the balloon material remaining from the heat set.
- work-out is intended to mean the application of a loading, e.g., inflating, coating, and/or heating of the balloon to reduce or undo the shape memory in the material that resulted from the balloon folds in the collapsed configuration, such as folds that were heat set in place.
- the balloon may be inflated and deflated several times as this may also help to work-out the shape memory properties.
- the deflated pressure for these embodiments may be near the collapsed configuration or relatively close to the less-than the intended maximum pressure, the maximum pressure or the hyper-inflated pressure level.
- the inflated pressure of the balloon may be cycled between ambient pressure and the intended maximum pressure, the intermediate pressure and the maximum pressure, etc.
- the temperature of the liquid or gas used to expand the balloon to the inflated state may be adjusted to other than ambient or room temperature, and the inflated state may be maintained for a period of time.
- the balloon may be expanded or contracted by a heated, chilled or cold fluid, respectively.
- a heated fluid can be defined as above 25 deg. C.
- the temperature can be below 200 deg. C., or alternatively below 150 deg. C., or alternatively below 100 deg. C., or alternatively below 75 deg. C.
- the temperature can be between 25 deg. C. and 100 deg. C.
- a cooled fluid can mean below 25 deg. C.
- a chilled fluid can mean below 0 deg. C.
- the balloon 10 is placed in a relaxed state, as depicted in FIG. 5 .
- the balloon 10 has a maximum radial extent 10 d , a surface having random depressions 10 e and irregular or random folds 10 c .
- a relaxed state is intended to mean the shape that the balloon takes after the pressure in the balloon is reduced from the inflated state.
- the relaxed state is such that when the stent is crimped to the balloon, new folds or creases replace prearranged folds from the collapsed configuration.
- the balloon is maintained at a pressure, such as greater than about one atmosphere for a relaxed state. In this case, the stent may be crimped onto the balloon while the internal pressure is allowed to release.
- the relaxed state corresponds to the balloon surface showing generally the same wings that it had in the collapsed configuration as a result of shape memory in the membrane, but the wings are partially formed.
- irregular or random folds form as a result of the circumferential forces during crimping, in spite of the presence of the partially reformed wings.
- some of the prearranged folds can be found on the balloon after crimping. In some embodiments, the prearranged folds are no longer present after crimping.
- the relaxed state for balloon 10 can correspond to a shape that shows a partial formation of the two spiral-wound wings 11 in FIG. 3B , but when the stent is crimped to the balloon 10 those wings 11 are no longer present.
- the prearranged folds are replaced by irregular or random folds 22 a that form as the stent 14 bears down on the balloon during crimping, as depicted in FIG. 8 .
- Irregular or random folds or wrinkles is intended to mean folds or wrinkles that are not formed in a prearranged manner.
- irregular or random folds or wrinkles e.g., folds 22 a ( FIG. 8 ) or 10 e ( FIG.
- the surface of the balloon may have substantially all, or only a portion of the folds from the collapsed configuration present in the relaxed state.
- the relaxed state is such that when the stent is crimped to the balloon, heat set folds are not reformed when the stent is crimped to the balloon. Rather, new creases or folds replace the heat set folds.
- a balloon pressure for the relaxed state may be arrived at by simply opening the valve 24 to allow fluid to exit from the balloon, or by a controlled release of the fluid.
- the fluid may be released continuously or in stages, e.g., 1 atm per minute, etc.
- a relaxed state corresponds to the shape of the balloon when the pressure inside is at about atmospheric pressure.
- the relaxed state is achieved when the balloon pressure is decreased to a pressure less than the pressure corresponding to the inflated state, e.g., 10-30%, less than 50%, 50-60%, 60-80%, 80-90%.
- the balloon pressure may be less than the maximum intended pressure but higher than ambient pressure.
- the balloon is allowed to deflate only by an amount sufficient to enable a stent to be easily placed over the balloon, or so that a stent may be snugly fit over the balloon.
- the aforementioned inflating and deflating steps may be repeated one or more times in order to arrive at a desired relaxed state.
- These additional steps in addition to other loadings of the balloon intended to work-out shape memory in the material, as discussed earlier, may be advantageous to further promote a more uniform expansion of the balloon.
- a more uniform expansion of the balloon is desirable because the balloon should be less likely to expand the stent in a irregular manner. Further, a more uniform expansion should equate to more uniform stiffness properties of the balloon over its surface and, in particular, in those areas proximal to bumps or mounds as compared to areas distal from bumps or mounds.
- the localized stress concentrations should not be as severe. This should reduce instances of crack propagation in a stent strut and/or undesired plastic deformations of the crimped stent.
- the stent is placed over the balloon, which is in a relaxed state. This stage of the process is depicted in FIG. 6 .
- the stent has struts 16 separated by gaps 18 .
- the balloon is inflated to atmospheric pressure or above atmospheric when in a relaxed state.
- the balloon may also be filled with a liquid when in the relaxed state.
- the balloon pressure may be up to an amount that allows the stent to be loosely placed on the balloon or snugly fit on the balloon.
- FIG. 7 depicts the stent 14 on the balloon 10 , and the balloon 10 in a relaxed state when in a crimping device 20 .
- the crimping device is designed to apply uniform radial compressive forces 21 to the outer stent surface sufficient to plastically deform the stent.
- the effect of the applied force 21 is shown in FIG. 8 .
- the balloon 10 has irregular or random folds 22 a but not the prearranged folds 11 present in the balloon's collapsed configuration ( FIGS. 3A and 3B ).
- the stent 14 may be fully crimped onto the balloon 10 in one step, or the stent 10 may be crimped on the balloon using any multi-step protocol known in the art provided it can be used or adapted for use consistent with the teachings of the invention.
- Crimping can be defined as the process of mounting, fastening or securing a stent on a balloon.
- the stent can then be fixedly carried by the balloon and deployed by inflation and subsequent withdrawal of the balloon in order to implant the stent at a target site, such as a region of stenosis.
- the crimp process can include selectively, radially compressing or applying pressure for positioning a stent on a balloon of a catheter assembly or an expandable delivery member of a catheter assembly.
- the compression or radial pressure during crimping can be segmented or uniform across the length and/or circumference of the stent.
- the application of pressure by the crimping device 20 can be continuous or applied in an intermittent or step-wise fashion.
- the balloon can be deflated and re-inflated until a final crimp configuration has been achieved.
- the stent may be partially crimped on the balloon, followed by the balloon pressure being increased.
- the balloon may also be heated prior or during crimping.
- the final configuration of the stent 14 as fully crimped is illustrated in FIG. 8 .
- Protrusions 22 of the balloon are disposed in the gaps 18 of the stent struts 16 . It has been found that in some embodiments, as a result of the aforementioned effects on balloon stiffness resulting from the disclosed inflation and deflation steps, i.e., more uniform stiffness properties, a stent's slip resistance from the balloon following crimping can be improved.
- the balloon material is more capable of protruding into the gaps 18 before or during crimping.
- the protrusions 22 may be used to increase the slip resistance of the stent.
- balloon material may more readily slip into gaps 18 by maintaining the balloon 10 in an inflated state while the stent is crimped.
- the valve 24 is regulated during crimping in order to relieve the balloon 10 pressure at a suitable rate as the stent continues to bear down on the balloon. For example, the pressure may be relieved at such a rate as to allow the balloon material sufficient time to fill or slip into the gaps but without increasing the balloon pressure beyond a safe limit.
- the protrusions 22 preferably do not extend beyond the outer surface of the struts 16 , while in other embodiments the protrusions 22 may extend beyond the outer surface of the struts 16 .
- the balloon may be heated to promote expansion of the balloon material into gaps 18 before or during crimping. When the balloon material is disposed within the gaps 18 , the balloon wall or membrane may become wedged, lodged, squeezed, or pinched between the struts 16 when the crimping process is completed.
- the crimping device can hold the balloon pressure at a desired pressure or temperature for a period of time prior to relief of pressure.
- the process of crimping can also include, unless otherwise specifically indicated, modifications made to the stent and/or balloon prior, during or subsequent to the application of crimping pressure that is directed to retention of the stent on the balloon.
- the balloon can have an adhesive coating to improve the retention of the stent on the balloon.
- the balloon can be dipped into a fluid or solvent such as acetone before sliding the stent on the balloon in order to soften the balloon material. This makes it easier for the balloon material to squeeze into the space between the stent struts.
- the solvents such as acetone, may also partially dissolve the surface of the stent or coating on the stent allowing for better adhesion between the stent and the balloon.
- a softening fluid can be used that is a non-solvent for the stent or the coating on the stent.
- the balloon 10 can be inflated by application of a fluid or a gas at a temperature other than ambient.
- a heated fluid or gas is used when the stent is crimped onto a deflating balloon.
- heated can be defined as above 25 deg. C.
- the temperature can be below 200 deg. C., or alternatively below 150 deg. C., or alternatively below 100 deg. C., or alternatively below 75 deg. C.
- the temperature can be between 25 deg. C. and 100 deg. C.
- the temperature is equal to or above the glass transition temperature (Tg) of a polymer of the stent body or a polymer of the stent coating (if applicable). In some embodiments, the temperature is equal to or above Tg but less than a melting temperature of a polymer of the stent body or a polymer of coating over the stent body.
- Tg glass transition temperature
- a cooled or chilled fluid or gas can be used to inflate the balloon. Cooled can mean below 25 deg. C. Chilled can mean below 0 deg. C.
- the outer surface of the balloon or the inner surface of a stent can include a coating, such as an adhesive coating, a drug delivery coating, a protective coating, a polymeric coating.
- a heat activated adhesive coating may be used.
- a polymer having a melting or glass transition temperature below that of a stent and balloon may be applied to the stent or balloon surfaces, and the stent and balloon heated to activate the coating so that the friction between stent and balloon is increased.
- the stent may be partially crimped and the balloon expanded by application of heat or inflated into the stent so that the balloon material begins to protrude into the gaps 18 prior to a final crimping step.
- FIG. 9A illustrates the balloon 10 and the stent 14 in the partially crimped configuration.
- FIG. 9B illustrates the final crimped configuration for this embodiment. It has been found that when the aforementioned inflating and deflating steps are carried out prior to this crimping protocol, the stent does not become skewed relative to the catheter or shifted axially along the balloon. The explanation for this behavior is understood in light of the previous discussion.
- the stent body itself is preferably made from a polymeric material such as one or a combination of polymers. In some embodiments, such body can be made from a combination of polymeric and metallic material(s). In some embodiments, the stent is biodegradable. Both polymers and metallic materials can be biodegradable. In one preferred embodiment, the stent is completely or exclusively made from a polymeric material or combination of polymeric materials, more specifically biodegradable polymer(s).
- a polymeric stent can include some metallic components for allowing the stent to be viewed during the procedure; however, the amount of material is insignificant, does not impart any structural function to the stent, or for viewing means only such that the stent is in essence made from a polymeric material or combination of polymers as is understood by one having ordinary skill in the art.
- metallic stents are completely excluded from any of the embodiments of this invention.
- Metallic stents have a stent body (i.e., struts or structural elements) made mostly or completely from a metallic material such as a pure metal or an alloy. It should be noted that biodegradable is intended to include bioabsorbable, bioerodable, etc. unless otherwise specifically indicated.
- the stent can include a drug coating.
- the coating can be a pure drug or combination of drugs.
- the coating can include a polymeric carrier for the drug, either a single polymer or multiple polymers.
- the coating can be layered as is understood by one of ordinary skilled in the art.
- the stent or the coating can be made from a material including, but are not limited to, poly(N-acetylglucosamine) (Chitin), Chitosan, poly(hydroxyvalerate), poly(lactide-co-glycolide), poly(hydroxybutyrate), poly(hydroxybutyrate-co-valerate), polyorthoester, polyanhydride, poly(glycolic acid), poly(glycolide), poly(L-lactic acid), poly(L-lactide), poly(D,L-lactic acid), poly(D,L-lactide), poly(caprolactone), poly(trimethylene carbonate), polyester amide, poly(glycolic acid-co-trimethylene carbonate), co-poly(ether-esters) (e.g.
- PEO/PLA polyphosphazenes
- biomolecules such as fibrin, fibrinogen, cellulose, starch, collagen and hyaluronic acid
- polyurethanes silicones
- polyesters polyolefins, polyisobutylene and ethylene-alphaolefin copolymers
- acrylic polymers and copolymers other than polyacrylates vinyl halide polymers and copolymers (such as polyvinyl chloride), polyvinyl ethers (such as polyvinyl methyl ether), polyvinylidene halides (such as polyvinylidene chloride), polyacrylonitrile, polyvinyl ketones, polyvinyl aromatics (such as polystyrene), polyvinyl esters (such as polyvinyl acetate), acrylonitrile-styrene copolymers, ABS resins, polyamides (such as Nylon 66 and polycaprolactam), polycarbonates, polyoxymethylenes, polyimides,
- poly(lactic acid) Another type of polymer based on poly(lactic acid) that can be used includes graft copolymers, and block copolymers, such as AB block-copolymers (“diblock-copolymers”) or ABA block-copolymers (“triblock-copolymers”), or mixtures thereof.
- graft copolymers such as AB block-copolymers (“diblock-copolymers”) or ABA block-copolymers (“triblock-copolymers”), or mixtures thereof.
- block copolymers such as AB block-copolymers (“diblock-copolymers”) or ABA block-copolymers (“triblock-copolymers”), or mixtures thereof.
- EVAL ethylene vinyl alcohol copolymer
- poly(butyl methacrylate) poly(vinylidene fluoride-co-hexafluororpropene)
- SOLEF 21508 available from Solvay Solexis PVDF, Thorofare, N.J.
- polyvinylidene fluoride otherwise
- a metal stent may also be used in conjunction with the above-described embodiments.
- the stent can be made of a pure metal or a metal alloy such as, but not limited to, stainless steel (316L), “MP35N,” “MP20N,” tantalum, nickel-titanium alloy, platinum-iridium alloy, gold, magnesium, or combinations thereof.
- MP35N and MP20N are trade names for alloys of cobalt, nickel, chromium and molybdenum available from standard Press Steel Co., Jenkintown, Pa.
- “MP35N” consists of 35% cobalt, 35% nickel, 20% chromium, and 10% molybdenum.
- “MP20N” consists of 50% cobalt, 20% nickel, 20% chromium, and 10% molybdenum.
- Stents made from bioabsorbable or biostable polymers could also be used with the embodiments of the present invention.
- the stent was then crimped to a designated diameter (0.053 in) in one step (from 0.136 in to 0.053 in) or several steps (from 0.136 in to 0.08 in, then to 0.053 in) in the range of 30 to 50 degrees Celsius.
- the crimping procedure included the steps of inflating the balloon before crimping, and after the stent was partially crimped to 0.08 in.
- the crimped stent was then sterilized by electronic beam radiation with a dose of about 25 kGray. The above procedure was performed for 30 stents. Only one of the crimped stents were observed to have very slight bent struts at one end after being crimped using the new crimping method, as observed under an optical microscope with 4 ⁇ magnification.
- Sample # indicates the particular sample from the respective lot. “25%” and “50%” refers to the length of a crack observed in a strut for a sample (as a percentage of the strut width). “Broken” indicates the number of broken struts following expansion for a sample. As evident from the data shown in TABLES 1 and 2, the new crimping method significantly reduces instances of cracked or broken struts after the crimped stent was expanded by the balloon, as compared to the control group.
- TABLE 3 shows results of performance tests for the stents crimped using the new crimping method (Lot B) compared to the control group (Lot A).
- the data presented in this table show that the new crimping method does not produce any adverse effects on retention or slip resistance, recoil, radial strength and modulus of the stents as compared to the control group.
- the stent retention test was evaluated by a dislodgement test. Two out of the five of stents crimped using the new crimping method were found to have a much higher holding force.
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Cardiology (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Transplantation (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Media Introduction/Drainage Providing Device (AREA)
Abstract
A balloon is inflated from a collapsed configuration, then deflated. A polymeric stem is then disposed over the deflated balloon and the stent crimped to the balloon.
Description
The application is a divisional of U.S. application Ser. No. 13/252,965 filed Oct. 4, 2011, which is a continuation of U.S. application Ser. No. 11/864,834 filed Sep. 28, 2007, now U.S. Pat. No. 8,046,897, the contents of which are hereby incorporated by reference in their entirety for all purposes.
TECHNICAL FIELDThis invention relates to methods of crimping a stent on a balloon, and a stent secured to a catheter assembly.
BACKGROUNDA stent, as illustrated in
FIG. 1, is an intravascular prosthesis that is delivered and implanted within a patient's vasculature or other bodily cavities and lumens by a balloon catheter. The structure of a stent is typically composed of scaffolding, substrate, or base material that includes a pattern or network of interconnecting structural elements often referred to in the art as struts or bar arms. Referring to
FIG. 1, an
exemplary stent14 is illustrated.
Stent14 can include a plurality of
struts16 connected by linking
struts11, with
interstitial spaces18 located in between the struts. The plurality of
struts16 can be configured in an annular fashion in discrete “rows” such that they form a series of “rings” throughout the body of
stent14. Stents can be used in percutaneous transluminal coronary angioplasty (PTCA) or percutaneous transluminal angioplasty (PTA). Conventional stents and catheters are disclosed by U.S. Pat. Nos. 4,733,665, 4,800,882, 4,886,062, 5,514,154, 5,569,295, and 5,507,768. In advancing a stent through a body vessel to a deployment site, the stent must be able to securely maintain its axial as well as rotational position on the delivery catheter without translocating proximally or distally, and especially without becoming separated from the catheter. Stents that are not properly secured or retained to the catheter may slip and either be lost or be deployed in the wrong location. The stent must be “crimped” in such a way as to minimize or prevent distortion of the stent and to thereby prevent abrasion and/or reduce trauma to the vessel walls.
Generally, stent crimping is the act of affixing the stent to the delivery catheter or delivery balloon so that it remains affixed to the catheter or balloon until the physician desires to deliver the stent at the treatment site. Current stent crimping technology is sophisticated. Examples of such technology which are known by one of ordinary skill in the art include a roll crimper; a collet crimper; and an iris or sliding-wedge crimper. To use a roll crimper, first the stent is slid loosely onto the balloon portion of the catheter. This assembly is placed between the plates of the roll crimper. With an automated roll crimper, the plates come together and apply a specified amount of force. They then move back and forth a set distance in a direction that is perpendicular to the catheter. The catheter rolls back and forth under this motion, and the diameter of the stent is reduced. The process can be broken down into more than one step, each with its own level of force, translational distance, and number of cycles. This process imparts a great deal of shear to the stent in a direction perpendicular to the catheter or catheter wall. Furthermore, as the stent is crimped, there is additional relative motion between the stent surface and the crimping plates.
The collet crimper is equally conceptually simple. A standard drill-chuck collet is equipped with several pie-piece-shaped jaws. These jaws move in a radial direction as an outer ring is turned. To use this crimper, a stent is loosely placed onto the balloon portion of a catheter and inserted in the center space between the jaws. Turning the outer ring causes the jaws to move inward. An issue with this device is determining or designing the crimping endpoint. One scheme is to engineer the jaws so that when they completely close, they touch and a center hole of a known diameter remains. Using this approach, turning the collet until the jaws abut each other crimps the stent to the known outer diameter. While this seems ideal, it can lead to problems. Stent struts have a tolerance on their thickness. Additionally, the process of folding non-compliant balloons is not exactly reproducible. Consequently, the collet crimper exerts a different amount of force on each stent in order to achieve the same final dimension. Unless this force, and the final crimped diameter, is carefully chosen, the variability of the stent and balloon dimensions can yield stent or balloon damage.
In the sliding wedge or iris crimper, adjacent pie-piece-shaped sections move inward and twist, much like the leaves in a camera aperture. This crimper can be engineered to have two different types of endpoints. It can stop at a final diameter, or it can apply a fixed force and allow the final diameter to float. From the discussion on the collet crimper, there are advantages in applying a fixed level of force as variability in strut and balloon dimension will not change the crimping force. The sliding wedges impart primarily normal forces. As the wedges slide over each other, they impart some tangential force. Lastly, the sliding wedge crimper presents a nearly cylindrical inner surface to the stent, even as it crimps. This means the crimping loads are distributed over the entire outer surface of the stent.
All current stent crimping methods were developed for all-metal stents. Stent metals, such as stainless steel, are durable and can take abuse. When crimping is too severe, it usually damages the underlying balloon, not the metal stent. But polymeric stents present different challenges. A polymer stent requires relatively wider struts than metal stents so as to provide suitable mechanical properties, such as radial strength. At the crimping stage, less space is provided between the struts which can result in worse stent retention than a metallic stent. Moreover, the use of high processing temperature during the crimping process to enhance stent retention may not be possible as a polymeric stent may have a glass transition temperature between 40-60 degrees Celsius. Higher processing temperatures may cause the stent to lose some of its preferred mechanical properties.
Polymeric stents can also be more susceptible to crack propagation during crimping or expansion by a balloon. When a polymeric stent is placed on a balloon and a crimping pressure applied, the load on the struts can vary significantly. A significant cause for this load variation is the balloon surface, which due to its variation in surface geometry and stiffness properties over the surface imposes non-uniform reaction forces to crimping against the stent luminal surface. As the stent is pressed into the balloon surface, different stent struts will experience different loadings because the balloon does not everywhere have the same stiffness properties, i.e., some areas are less compliant than others. Moreover, the balloon surface is generally not smooth. As such, bumps or mounds over the balloon surface, especially in areas of relatively high stiffness, can produce different loadings across the stent body. For example, when a stent is crimped on a non-compliant balloon having folded wings or pleats, there can be noticeable bumps or mounds in the areas where the material is folded. Moreover, the stiffness in these areas, i.e., where the balloon material is folded over itself, can be noticeable higher than in areas distal from the folds. Variations in the surface geometry of the balloon and/or stiffness about the circumference and/or length of the balloon can lead to high stress concentrations resulting in twisting, bending, warping of individual struts or segments of the stent. Excessive loading in areas near corners, especially corners having surface imperfections created during the stent making process (typically a high stress area), can result in propagation of micro cracks leading to a significant reduction in strength or outright failure of a strut when the stent is expanded to its full diameter by the balloon.
The present invention provides a novel method of crimping a stent, more specifically a polymeric stent on an expandable member or a balloon, and a novel apparatus for delivery of a stent on a balloon catheter.
SUMMARYIn accordance with one embodiment, a method of crimping a stent on a balloon of a catheter assembly includes inflating a balloon, deflating the balloon, disposing the stent over the balloon after deflating the balloon, and then crimping the stent to the balloon. The balloon may be inflated to an intermediate pressure, maximum pressure, or hyper-inflated pressure for the balloon before being deflated. Various crimping procedures known in the art may be used. In some embodiments, the crimping procedure may include a step in which the balloon is re-inflated when the stent is disposed over the balloon. In some embodiments, the deflating step may deflate the balloon to about atmospheric pressure.
In some embodiments, the act of inflating the balloon inflates a balloon configured in a collapsed configuration, such that the balloon has prearranged folds that are heat set. When the balloon is inflated, the heat set folds are removed, or substantially removed from the balloon. When the balloon is deflated, the balloon may partially reform the folds.
In another embodiment, a method of securing a stent on a balloon of a catheter assembly, the balloon having pre-arranged folds when configured in a collapsed configuration, includes the steps of inflating the balloon such that the folds are substantially or completely removed, and crimping the stent to the balloon after the folds are substantially or completely removed. In some embodiments, the balloon is configured in a collapsed configuration, the folds are such as to form shape memory in a membrane of the balloon, and the crimping step includes crimping the stent to the balloon configured such that a portion of the shape memory in the balloon is still present in the membrane. During the crimping step, the balloon may be compressed such that at least a portion of the folds present in the collapsed configuration are replaced by irregular folds.
According to another embodiment, a method of crimping a stent to a balloon includes the steps of inflating the balloon from an initial diameter to a final diameter, deflating the balloon such that the balloon forms a relaxed state, and after deflating the balloon, crimping the stent to the balloon. In some embodiments, the balloon pressure is reduced to about atmospheric when the balloon is in the relaxed state.
According to another embodiment, a balloon catheter includes a balloon of the type having a membrane predisposed to form at least one prearranged fold when in a collapsed configuration, the balloon being configured in a compressed configuration such that the at least one prearranged fold is replaced by at least one irregular fold in the compressed configuration, and a stent secured to the balloon.
According to another embodiment, a balloon catheter includes a balloon of the type configured to have at least one prearranged fold when in a collapsed configuration, and a stent compressed onto the balloon such that the balloon is devoid of the at least one prearranged fold. In some embodiments, the balloon is a non-compliant balloon. In some embodiments, the balloon has a plurality of prearranged folds when configured in a collapsed configuration, and when the stent is compressed onto the balloon the plurality of folds are replaced by folds resulting from the compression of the stent onto the balloon.
In one aspect, embodiments of a method and apparatus are disclosed that can reduce the instances of failed or bent stent struts during crimping and/or subsequent expansion of the stent by a balloon catheter. In another aspect, the disclosure provides a method and apparatus to improve stent retention and uniform expansion of the stent. In another aspect, the disclosure provides a method and apparatus for an improved manufacturing procedure, such as elimination of time consuming steps and improved quality control when stents are secured to a balloon.
DESCRIPTION OF FIGURESThe figures have not been drawn to scale and portions thereof have been under or over emphasized for illustrative purposes.
is a perspective view of a stent;
illustrate crimped stents that have struts misaligned by a crimping process.
show side and axial views, respectively, of a balloon catheter with a balloon configured in a collapsed configuration;
show side and axial views, respectively, of the balloon when inflated.
illustrates the balloon in
FIG. 4Aafter having being deflated;
illustrates a side view of the balloon of
FIG. 5with a stent disposed over the balloon;
illustrate a crimping step for the stent to the balloon and the balloon and stent following crimping.
illustrate an alternative crimping procedure.
Embodiments of the stent crimping methods of the invention disclosed herein are suitable to adequately and uniformly crimp a balloon expandable stent onto a balloon or expandable member of a catheter assembly. The embodiments of the invention may also be applicable to stent-grafts. In one embodiment, the method of the present invention is particularly directed to crimping of a biodegradable, polymeric stent on a balloon of a catheter assembly. A biodegradable polymer stent has many advantages over non-biodegradable metal stents, including the ability to be disposed in the body only for the duration of time until the intended function of the stent has been performed.
Crimping of polymer stents has proven more challenging than metal stents. A polymer, having generally less favorable stress/strain properties than a metal, is more likely to become damaged during crimping as compared to a metal stent. High stresses are better handled by a metal stent due to its inherent material properties. Polymeric stents, however, can fracture when faced with a similar crimp loading. As such, a polymer stent is generally less tolerant of localized high stresses resulting from non-uniform applied loads that can occur when the stent is pressed into a balloon.
illustrate four different polymeric stents crimped to balloons. Ideally, all struts for this particular stent should extend parallel to the longitudinal axis after crimping. However, in each of these figures one or more stent struts or rings has been twisted, bent or misaligned in an desired way, i.e., deformed such that struts do not extend parallel to the longitudinal axis as intended.
FIG. 2Ashows an
over-compressed ring19 a at the end of the stent in which struts abut each other and are twisted downward. The stent in
FIG. 2Bshows a similar situation for the struts of
ring19 b, also located at the end. Additionally, it can be seen in the stent of
FIG. 2Bthat the rings
adjacent ring19 b are twisted upward. In
FIG. 4Cit can be seen that an entire row of
struts19 c are twisted upwards or downwards. As mentioned above, it is preferred by design that all struts for this stent extend parallel to the stent longitudinal axis when the stent is crimped to the balloon.
FIG. 2Dshows a similar undesired deformity for
ring19 d. Additionally,
ring19 e located closer to the center of the stent in
FIG. 2Dalso has an desired twist in its struts. When these stents are expanded by the balloon, some of the aforementioned misalignment, twisting or bending may be undone. In other cases balloon expansion may not straighten out these struts and/or rings. Worse yet, balloon expansion may cause one or more of the misaligned struts to fail. In these cases, it is believed that the above noted undesirable deformations were due in large part to variations in surface contour and/or compliance characteristics of the balloon surface which received the stent during crimping.
Retention of a polymer stent on a balloon of a delivery catheter while it is passed through a body lumen has proven more challenging than that of a metallic stent. Polymer stents can require wider struts than metal stents so as to provide suitable mechanical properties, such as radial strength, for the stent. At the crimping stage, less space is provided between the struts which can result in worse stent retention than a metallic stent. Moreover, the use of high processing temperature during the crimping process to enhance stent retention may not be possible as a polymeric stent may have a glass transition temperature close to body temperature. Higher processing temperatures may cause the polymeric stent to lose some of its preferred mechanical properties.
Additionally, stents can shift on a balloon during a crimping process. For example, if the balloon is inflated while the stent is disposed over the balloon in a crimping machine, the stent longitudinal axis can become skewed from the balloon longitudinal axis, or the stent can shift axially. If this should occur, the stent and balloon will need to be removed from the crimping machine, the stent re-centered and the crimping protocol re-started. It is believed that this misalignment is usually due to non-uniform expansion characteristics of folded balloons. For example, some wings or pleats of a folded balloon may unfold faster than others. This can produce a net torque on the stent over its length, or unequal radial expansion when the balloon is viewed in a plane perpendicular to the longitudinal axis. Friction between layers or inconsistent pre-loading of folds when wings are formed are factors contributing to uneven balloon expansion.
show side and cross-sectional views of an expandable member, such as a
balloon10, integrated at a distal end of a
catheter assembly12. The
catheter12 includes a
valve24 to relieve balloon pressure and a pressure source (not shown). In some embodiments, the
balloon10 is intended to include any type of enclosed member such as an elastic type member that is selectively inflatable to dilate from a collapsed configuration to a desired and controlled expanded configuration. The
balloon10 should also be capable of being deflated to a reduced profile or back to its original collapsed configuration. The
balloon10 can be made from any suitable type of material and can be of any thickness so long as the ability to crimp the stent onto the balloon and optimum performance capabilities of the balloon are not adversely compromised. Performance properties include, for example, high burst strength, good flexibility, high resistance to fatigue, an ability to fold, and ability to cross and re-cross a desired region of treatment or an occluded region in a bodily lumen, and a low susceptibility to defects caused by handling and crimping, among other possibilities.
The balloon is illustrated in
FIG. 3Ain a collapsed configuration. The collapsed configuration can be the configuration that is conventionally used during the process of crimping of a stent on a balloon. In the collapsed configuration, the
balloon10 includes no liquid or gas in the internal chamber of the
balloon10. Such collapsed configuration can be the configuration of introduction and navigation of the
balloon10 in the vascular system of a patient and may be referred to as a configuration of the balloon in which the balloon has a minimum profile. The
diameter10 a of the
balloon10 is then the minimum diameter for the balloon. The balloon can be folded when in the collapsed configuration, which is the typical case for collapsed non-compliant balloons. The folds in a collapsed configuration are prearranged folds, meaning that the balloon material is folded according to a particular pattern or design intended to achieve an objective, e.g., a minimum profile. The folding is undertaken in an orderly manner either by hand or by a machine process. The folded parts of the balloons are often referred to as wings or pleats. The balloon is then typically heat set to hold the wings or pleats in place. For non-compliant balloons, which use material that is essentially non-elastic within the balloon operating ranges, the balloon inflates when wings or pleats have unfolded. As such, non-compliant balloons sometimes have several tightly wound layers of prearranged folded balloon material when in the collapsed configuration in order to achieve a minimum profile or diameter for the balloon.
depicts the
balloon10 folded in such a manner so as to create two opposing, prearranged wings or pleats 11, each having prearranged kinks or folds 11 a, 11 b. In other embodiments, the catheter may have a balloon that has more than two wings. Balloons may be folded in a spiral or accordion like fashion, each approach to achieve a specific objective, e.g., low profile, uniform expansion, reduced manufacturing complexity or quality control. Once folded, the
balloon10 is heat set so that folds 11 are maintained. The heat set can be such that if the balloon pressure is increased enough to unfold the wings, and then the balloon pressure is reduced back to below atmospheric, the balloon will take the same shape as it had prior to inflation.
Embodiments of the invention include the known types of collapsed balloon configurations, provided they are capable of being crimped to a stent and then delivered to a site within the body according to the disclosure. Stents crimped to compliant and semi-compliant balloons may also benefit from the teachings of the invention. As such, stent delivery systems that use compliant and semi-compliant balloons are also considered within the scope of the invention. Balloon folding techniques and balloon types are discussed in greater detail in U.S. Pat. Nos. 5,556,383, 6,488,688 and U.S. Pub. No. 2005/0244533, the entire contents of which are incorporated by reference as examples of the state of the art in this area.
Methods according to some embodiments of the invention can include an inflation of the balloon from a collapsed configuration to an inflated state, a deflation of the balloon from the inflated state, and then crimping the stent to the balloon using any known crimping procedure, provided those procedures are not inconsistent with the disclosure. The suitable choices for the crimping device and/or procedure that may be used in connection with embodiments of the invention will be understood from the disclosure. The crimping, inflation and deflation aspects of the disclosure may each include additional steps or processes, some of which are disclosed herein while others would be readily apparent based on the disclosure.
According to a disclosed embodiment, a method for securing a stent to a balloon begins with inflation of the
balloon10 to an inflated state, as shown in
FIG. 4A. In this state, the
balloon10 has an inflated
diameter10 b. In some embodiments, all balloon folds are removed, substantially all balloon folds are removed, the balloon is fully unfolded or the balloon is substantially fully unfolded in the inflated state. In some embodiments, the balloon takes its final expanded shape, e.g., cylindrical, or substantially its final expanded shape, when the balloon is in the inflated state.
The inflated shape may also be understood in terms of the internal balloon pressure when the balloon is in the inflated state, instead of the balloon shape. The
balloon10 is inflated by a pressure source (not shown) connected to the proximal end of the
catheter12 in
FIG. 4A. The inflated state may be achieved after the balloon is inflated to a maximum intended pressure or design pressure, an intermediate pressure, a hyper-inflated pressure. In some embodiments, a balloon inflated to any pressure that causes the balloon to at least partially expand places the balloon in an inflated state. Such embodiments include those in which the pressure is sufficient to break any friction between folded wings in the balloon material. A maximum intended pressure refers to a balloon pressure considered the highest from a standpoint of acceptable risk of damage to the balloon as prescribed under a standard medical protocol. A balloon manufacturer can supply this information or it can be determined using known methods. The maximum intended pressure may also refer to the diameter of the balloon when fully expanded, e.g.,
diameter10 b in
FIG. 4A. In the case of non-compliant balloon this would correspond to the outer balloon diameter after the wings have been fully unfolded. The maximum intended pressure may also refer to the balloon pressure that produces approximately the largest diameter designated for clinical use, in the case of compliant or semi-compliant balloons.
In some embodiments, the inflated state may correspond to a hyper-inflated balloon. Hyper-inflation is defined as any pressure or size above the intended expanded configuration but less than a pressure or size that creates an unacceptable risk that the balloon will be damaged. For example, a hyper-inflated pressure for a 3.0 mm balloon would be an applied balloon pressure that causes the balloon to expand to 3.5 mm or 4.0 mm, which diameters should usually not cause balloon damage. Balloon diameter tolerances depend on the type of balloon and the material from which the balloon is made, among other factors. The manufacturer of the balloon can provide such information to a user, for example.
An intermediate pressure refers to a pressure that, while not reaching the maximum intended pressure, is sufficient to substantially remove the folds or kinks in the balloon material when the balloon was in the collapsed configuration, or places the balloon in a substantially unfolded configuration. For example, an intermediate pressure for the
balloon10 would be the pressure sufficient to substantially undo the
kinks11 a and 11 b caused by the folded, collapsed configuration in
FIG. 3B, but less than the maximum intended pressure for
balloon10.
FIG. 4Bdepicts the
balloon10 when inflated to an intermediate pressure. Thus,
FIG. 4Bis one example of a balloon were the folds are substantially removed. The places on the balloon material where the balloon material was folded over itself, i.e., kinks or folds 11 a, 11 b, cannot be identified. Also, the balloon has taken an essentially circular shape.
A softening agent can be applied to the balloon surface before, during or after the inflated state has been reached. This can make the balloon surface softer or more pliable and can also help to work-out some of the shape memory properties of the balloon material remaining from the heat set. The term “work-out” is intended to mean the application of a loading, e.g., inflating, coating, and/or heating of the balloon to reduce or undo the shape memory in the material that resulted from the balloon folds in the collapsed configuration, such as folds that were heat set in place. The balloon may be inflated and deflated several times as this may also help to work-out the shape memory properties. The deflated pressure for these embodiments may be near the collapsed configuration or relatively close to the less-than the intended maximum pressure, the maximum pressure or the hyper-inflated pressure level. For example, the inflated pressure of the balloon may be cycled between ambient pressure and the intended maximum pressure, the intermediate pressure and the maximum pressure, etc.
The temperature of the liquid or gas used to expand the balloon to the inflated state may be adjusted to other than ambient or room temperature, and the inflated state may be maintained for a period of time. For example, the balloon may be expanded or contracted by a heated, chilled or cold fluid, respectively. In some embodiments, a heated fluid can be defined as above 25 deg. C. In some embodiments, the temperature can be below 200 deg. C., or alternatively below 150 deg. C., or alternatively below 100 deg. C., or alternatively below 75 deg. C. In some embodiments, the temperature can be between 25 deg. C. and 100 deg. C. A cooled fluid can mean below 25 deg. C. A chilled fluid can mean below 0 deg. C.
Subsequent to configuring the
balloon10 in an inflated state, the balloon is placed in a relaxed state, as depicted in
FIG. 5. For this embodiment, the
balloon10 has a maximum
radial extent10 d, a surface having
random depressions10 e and irregular or
random folds10 c. A relaxed state is intended to mean the shape that the balloon takes after the pressure in the balloon is reduced from the inflated state. In some embodiments the relaxed state is such that when the stent is crimped to the balloon, new folds or creases replace prearranged folds from the collapsed configuration. In some embodiments, the balloon is maintained at a pressure, such as greater than about one atmosphere for a relaxed state. In this case, the stent may be crimped onto the balloon while the internal pressure is allowed to release.
In some embodiments, the relaxed state corresponds to the balloon surface showing generally the same wings that it had in the collapsed configuration as a result of shape memory in the membrane, but the wings are partially formed. When the stent is subsequently crimped to the balloon, irregular or random folds form as a result of the circumferential forces during crimping, in spite of the presence of the partially reformed wings. In some embodiments, some of the prearranged folds can be found on the balloon after crimping. In some embodiments, the prearranged folds are no longer present after crimping.
For example, the relaxed state for
balloon10 can correspond to a shape that shows a partial formation of the two spiral-
wound wings11 in
FIG. 3B, but when the stent is crimped to the
balloon10 those
wings11 are no longer present. Instead, the prearranged folds are replaced by irregular or
random folds22 a that form as the
stent14 bears down on the balloon during crimping, as depicted in
FIG. 8. Irregular or random folds or wrinkles is intended to mean folds or wrinkles that are not formed in a prearranged manner. In some embodiments, irregular or random folds or wrinkles, e.g., folds 22 a (
FIG. 8) or 10 e (
FIG. 5) describe the appearance of the balloon when left to form folds or wrinkles, either as the balloon membrane collapses under its own weight, e.g., folds 10 e in
FIG. 5, or when prearranged folds from the collapsed configuration are replaced by new folds or wrinkles during crimping, e.g., folds 22 e in
FIG. 8. In some embodiments the surface of the balloon may have substantially all, or only a portion of the folds from the collapsed configuration present in the relaxed state. In some embodiments, the relaxed state is such that when the stent is crimped to the balloon, heat set folds are not reformed when the stent is crimped to the balloon. Rather, new creases or folds replace the heat set folds.
A balloon pressure for the relaxed state may be arrived at by simply opening the
valve24 to allow fluid to exit from the balloon, or by a controlled release of the fluid. The fluid may be released continuously or in stages, e.g., 1 atm per minute, etc. In some embodiments, a relaxed state corresponds to the shape of the balloon when the pressure inside is at about atmospheric pressure. In other embodiments the relaxed state is achieved when the balloon pressure is decreased to a pressure less than the pressure corresponding to the inflated state, e.g., 10-30%, less than 50%, 50-60%, 60-80%, 80-90%. In some embodiments, the balloon pressure may be less than the maximum intended pressure but higher than ambient pressure. In some embodiments, the balloon is allowed to deflate only by an amount sufficient to enable a stent to be easily placed over the balloon, or so that a stent may be snugly fit over the balloon.
In some embodiments, the aforementioned inflating and deflating steps may be repeated one or more times in order to arrive at a desired relaxed state. These additional steps, in addition to other loadings of the balloon intended to work-out shape memory in the material, as discussed earlier, may be advantageous to further promote a more uniform expansion of the balloon. A more uniform expansion of the balloon is desirable because the balloon should be less likely to expand the stent in a irregular manner. Further, a more uniform expansion should equate to more uniform stiffness properties of the balloon over its surface and, in particular, in those areas proximal to bumps or mounds as compared to areas distal from bumps or mounds. As such, when the stent is pressed into the balloon during crimping the localized stress concentrations should not be as severe. This should reduce instances of crack propagation in a stent strut and/or undesired plastic deformations of the crimped stent.
After the deflating step, the stent is placed over the balloon, which is in a relaxed state. This stage of the process is depicted in
FIG. 6. The stent has
struts16 separated by
gaps18. As indicated above, in some embodiments the balloon is inflated to atmospheric pressure or above atmospheric when in a relaxed state. The balloon may also be filled with a liquid when in the relaxed state. The balloon pressure may be up to an amount that allows the stent to be loosely placed on the balloon or snugly fit on the balloon.
FIG. 7depicts the
stent14 on the
balloon10, and the
balloon10 in a relaxed state when in a crimping
device20. The crimping device is designed to apply uniform radial
compressive forces21 to the outer stent surface sufficient to plastically deform the stent. The effect of the applied
force21 is shown in
FIG. 8. As depicted in
FIG. 9, the
balloon10 has irregular or
random folds22 a but not the prearranged folds 11 present in the balloon's collapsed configuration (
FIGS. 3A and 3B).
The
stent14 may be fully crimped onto the
balloon10 in one step, or the
stent10 may be crimped on the balloon using any multi-step protocol known in the art provided it can be used or adapted for use consistent with the teachings of the invention. Crimping can be defined as the process of mounting, fastening or securing a stent on a balloon. The stent can then be fixedly carried by the balloon and deployed by inflation and subsequent withdrawal of the balloon in order to implant the stent at a target site, such as a region of stenosis. The crimp process can include selectively, radially compressing or applying pressure for positioning a stent on a balloon of a catheter assembly or an expandable delivery member of a catheter assembly. The compression or radial pressure during crimping can be segmented or uniform across the length and/or circumference of the stent. The application of pressure by the crimping
device20 can be continuous or applied in an intermittent or step-wise fashion. In these embodiments, the balloon can be deflated and re-inflated until a final crimp configuration has been achieved.
The stent may be partially crimped on the balloon, followed by the balloon pressure being increased. The balloon may also be heated prior or during crimping. The final configuration of the
stent14 as fully crimped is illustrated in
FIG. 8.
Protrusions22 of the balloon are disposed in the
gaps18 of the stent struts 16. It has been found that in some embodiments, as a result of the aforementioned effects on balloon stiffness resulting from the disclosed inflation and deflation steps, i.e., more uniform stiffness properties, a stent's slip resistance from the balloon following crimping can be improved. In these embodiments, the balloon material is more capable of protruding into the
gaps18 before or during crimping. And when disposed in the
gaps18, the
protrusions22 may be used to increase the slip resistance of the stent. In some embodiments, balloon material may more readily slip into
gaps18 by maintaining the
balloon10 in an inflated state while the stent is crimped. The
valve24 is regulated during crimping in order to relieve the
balloon10 pressure at a suitable rate as the stent continues to bear down on the balloon. For example, the pressure may be relieved at such a rate as to allow the balloon material sufficient time to fill or slip into the gaps but without increasing the balloon pressure beyond a safe limit. In one embodiment, the
protrusions22 preferably do not extend beyond the outer surface of the
struts16, while in other embodiments the
protrusions22 may extend beyond the outer surface of the
struts16. In some embodiments, the balloon may be heated to promote expansion of the balloon material into
gaps18 before or during crimping. When the balloon material is disposed within the
gaps18, the balloon wall or membrane may become wedged, lodged, squeezed, or pinched between the
struts16 when the crimping process is completed.
In some embodiments, the crimping device can hold the balloon pressure at a desired pressure or temperature for a period of time prior to relief of pressure. The process of crimping can also include, unless otherwise specifically indicated, modifications made to the stent and/or balloon prior, during or subsequent to the application of crimping pressure that is directed to retention of the stent on the balloon. For example, the balloon can have an adhesive coating to improve the retention of the stent on the balloon. In some embodiments, the balloon can be dipped into a fluid or solvent such as acetone before sliding the stent on the balloon in order to soften the balloon material. This makes it easier for the balloon material to squeeze into the space between the stent struts. The solvents, such as acetone, may also partially dissolve the surface of the stent or coating on the stent allowing for better adhesion between the stent and the balloon. In some embodiments, a softening fluid can be used that is a non-solvent for the stent or the coating on the stent.
During the crimping stage, as with the inflation stage, the
balloon10 can be inflated by application of a fluid or a gas at a temperature other than ambient. In one embodiment, a heated fluid or gas is used when the stent is crimped onto a deflating balloon. In some embodiments, heated can be defined as above 25 deg. C. In some embodiments, the temperature can be below 200 deg. C., or alternatively below 150 deg. C., or alternatively below 100 deg. C., or alternatively below 75 deg. C. In some embodiments, the temperature can be between 25 deg. C. and 100 deg. C. In some embodiments, the temperature is equal to or above the glass transition temperature (Tg) of a polymer of the stent body or a polymer of the stent coating (if applicable). In some embodiments, the temperature is equal to or above Tg but less than a melting temperature of a polymer of the stent body or a polymer of coating over the stent body. In some embodiments, a cooled or chilled fluid or gas can be used to inflate the balloon. Cooled can mean below 25 deg. C. Chilled can mean below 0 deg. C.
In some embodiments, the outer surface of the balloon or the inner surface of a stent can include a coating, such as an adhesive coating, a drug delivery coating, a protective coating, a polymeric coating. If it is desirable instead to increase, not decrease friction, a heat activated adhesive coating may be used. For example, a polymer having a melting or glass transition temperature below that of a stent and balloon may be applied to the stent or balloon surfaces, and the stent and balloon heated to activate the coating so that the friction between stent and balloon is increased.
In another embodiment, the stent may be partially crimped and the balloon expanded by application of heat or inflated into the stent so that the balloon material begins to protrude into the
gaps18 prior to a final crimping step.
FIG. 9Aillustrates the
balloon10 and the
stent14 in the partially crimped configuration.
FIG. 9Billustrates the final crimped configuration for this embodiment. It has been found that when the aforementioned inflating and deflating steps are carried out prior to this crimping protocol, the stent does not become skewed relative to the catheter or shifted axially along the balloon. The explanation for this behavior is understood in light of the previous discussion.
The stent body itself is preferably made from a polymeric material such as one or a combination of polymers. In some embodiments, such body can be made from a combination of polymeric and metallic material(s). In some embodiments, the stent is biodegradable. Both polymers and metallic materials can be biodegradable. In one preferred embodiment, the stent is completely or exclusively made from a polymeric material or combination of polymeric materials, more specifically biodegradable polymer(s). A polymeric stent can include some metallic components for allowing the stent to be viewed during the procedure; however, the amount of material is insignificant, does not impart any structural function to the stent, or for viewing means only such that the stent is in essence made from a polymeric material or combination of polymers as is understood by one having ordinary skill in the art. In some embodiments, metallic stents are completely excluded from any of the embodiments of this invention. Metallic stents have a stent body (i.e., struts or structural elements) made mostly or completely from a metallic material such as a pure metal or an alloy. It should be noted that biodegradable is intended to include bioabsorbable, bioerodable, etc. unless otherwise specifically indicated.
In some embodiments, the stent can include a drug coating. The coating can be a pure drug or combination of drugs. The coating can include a polymeric carrier for the drug, either a single polymer or multiple polymers. The coating can be layered as is understood by one of ordinary skilled in the art.
The stent or the coating can be made from a material including, but are not limited to, poly(N-acetylglucosamine) (Chitin), Chitosan, poly(hydroxyvalerate), poly(lactide-co-glycolide), poly(hydroxybutyrate), poly(hydroxybutyrate-co-valerate), polyorthoester, polyanhydride, poly(glycolic acid), poly(glycolide), poly(L-lactic acid), poly(L-lactide), poly(D,L-lactic acid), poly(D,L-lactide), poly(caprolactone), poly(trimethylene carbonate), polyester amide, poly(glycolic acid-co-trimethylene carbonate), co-poly(ether-esters) (e.g. PEO/PLA), polyphosphazenes, biomolecules (such as fibrin, fibrinogen, cellulose, starch, collagen and hyaluronic acid), polyurethanes, silicones, polyesters, polyolefins, polyisobutylene and ethylene-alphaolefin copolymers, acrylic polymers and copolymers other than polyacrylates, vinyl halide polymers and copolymers (such as polyvinyl chloride), polyvinyl ethers (such as polyvinyl methyl ether), polyvinylidene halides (such as polyvinylidene chloride), polyacrylonitrile, polyvinyl ketones, polyvinyl aromatics (such as polystyrene), polyvinyl esters (such as polyvinyl acetate), acrylonitrile-styrene copolymers, ABS resins, polyamides (such as Nylon 66 and polycaprolactam), polycarbonates, polyoxymethylenes, polyimides, polyethers, polyurethanes, rayon, rayon-triacetate, cellulose, cellulose acetate, cellulose butyrate, cellulose acetate butyrate, cellophane, cellulose nitrate, cellulose propionate, cellulose ethers, and carboxymethyl cellulose. Another type of polymer based on poly(lactic acid) that can be used includes graft copolymers, and block copolymers, such as AB block-copolymers (“diblock-copolymers”) or ABA block-copolymers (“triblock-copolymers”), or mixtures thereof.
Additional representative examples of polymers that may be especially well suited for use in fabricating or coating the stent include ethylene vinyl alcohol copolymer (commonly known by the generic name EVOH or by the trade name EVAL), poly(butyl methacrylate), poly(vinylidene fluoride-co-hexafluororpropene) (e.g., SOLEF 21508, available from Solvay Solexis PVDF, Thorofare, N.J.), polyvinylidene fluoride (otherwise known as KYNAR, available from ATOFINA Chemicals, Philadelphia, Pa.), ethylene-vinyl acetate copolymers, and polyethylene glycol.
A metal stent may also be used in conjunction with the above-described embodiments. The stent can be made of a pure metal or a metal alloy such as, but not limited to, stainless steel (316L), “MP35N,” “MP20N,” tantalum, nickel-titanium alloy, platinum-iridium alloy, gold, magnesium, or combinations thereof. “MP35N” and “MP20N” are trade names for alloys of cobalt, nickel, chromium and molybdenum available from standard Press Steel Co., Jenkintown, Pa. “MP35N” consists of 35% cobalt, 35% nickel, 20% chromium, and 10% molybdenum. “MP20N” consists of 50% cobalt, 20% nickel, 20% chromium, and 10% molybdenum. Stents made from bioabsorbable or biostable polymers could also be used with the embodiments of the present invention.
EXAMPLEPolymeric stents were crimped onto balloon catheters using a procedure consistent with the disclosure (hereinafter the “new crimping method”). For this test, a 3.0 mm non-compliant balloon was dilated from a collapsed configuration to an inflated state of between 12-20 psi, then deflated so that the stent internal pressure was about equal to atmospheric pressure. In this relaxed state, a laser cut polymeric stent (OD=0.136 in) was placed on the balloon and aligned between two marker bands. The stent and balloon were then placed into a crimping machine. The stent was then crimped to a designated diameter (0.053 in) in one step (from 0.136 in to 0.053 in) or several steps (from 0.136 in to 0.08 in, then to 0.053 in) in the range of 30 to 50 degrees Celsius. The crimping procedure included the steps of inflating the balloon before crimping, and after the stent was partially crimped to 0.08 in. The crimped stent was then sterilized by electronic beam radiation with a dose of about 25 kGray. The above procedure was performed for 30 stents. Only one of the crimped stents were observed to have very slight bent struts at one end after being crimped using the new crimping method, as observed under an optical microscope with 4× magnification. As a control group, a different lot of the 30 laser cut stents were crimped onto 3.0 mm non-compliant balloons using the same crimping procedure as above, but without inflating and deflating the balloon before crimping. In this group, seven stents with bent struts or uneven alignment were observed under the optical microscope at 4× magnification.
Ten stents crimped using the new crimping method, and ten stents from the control group were expanded by the balloon and subjected to accelerated aging (40 degrees Celsius) at 24 hour and 65 hour time points. The expanded stents from both groups were then inspected for cracks or fractures after being expanded by the balloon. For purposes of this test, the stents with designed expanded diameters of 3.0 mm were over-expanded to 3.5 mm, and then 4.0 mm diameters. TABLES 1 and 2 show the number of cracked and broken stents found in the stents crimped according to the new crimping method (“Lot B”) versus the stents crimped for the control group (“Lot A”).
TABLE 1 |
Expansion Results (24 hour accelerated aging time point) |
Expansion | Deployed to 3.5 mm | Deployed to 4.0 mm |
Sample # | 25% | 50% | Broken | 25% | 50% | Broken | |
Lot A | 6 | 2 | 0 | 0 | 4 | 2 | 1 |
28 | 2 | 1 | 0 | 2 | 1 | 3 | |
29 | 3 | 0 | 0 | 4 | 1 | 0 | |
34 | 13 | 7 | 0 | 16 | 7 | 2 | |
36 | 4 | 0 | 0 | 6 | 1 | 0 | |
Lot B | 26 | 2 | 0 | 0 | 5 | 1 | 0 |
45 | 5 | 0 | 0 | 7 | 0 | 0 | |
46 | 2 | 0 | 0 | 4 | 1 | 0 | |
47 | 0 | 0 | 0 | 2 | 0 | 0 | |
48 | 0 | 0 | 0 | 0 | 0 | 0 | |
TABLE 2 |
Expansion Results (65 hour accelerated aging time point) |
Expansion | Deployed to 3.5 mm | Deployed to 4.0 mm |
Sample # | 25% | 50% | Broken | 25% | 50% | Broken | |
Lot A | 5 | 5 | 0 | 1 | 7 | 2 | 3 |
20 | 5 | 3 | 0 | 9 | 2 | 7 | |
24 | 7 | 4 | 0 | 4 | 1 | 9 | |
32 | 8 | 4 | 0 | 10 | 1 | 7 | |
33 | 3 | 1 | 0 | 5 | 2 | 2 | |
Lot B | 27 | 2 | 0 | 0 | 5 | 0 | 0 |
34 | 8 | 0 | 0 | 9 | 0 | 0 | |
38 | 4 | 0 | 0 | 4 | 1 | 1 | |
40 | 8 | 3 | 0 | 5 | 3 | 5 | |
51 | 5 | 0 | 0 | 7 | 0 | 0 | |
“Sample #” indicates the particular sample from the respective lot. “25%” and “50%” refers to the length of a crack observed in a strut for a sample (as a percentage of the strut width). “Broken” indicates the number of broken struts following expansion for a sample. As evident from the data shown in TABLES 1 and 2, the new crimping method significantly reduces instances of cracked or broken struts after the crimped stent was expanded by the balloon, as compared to the control group.
TABLE 3 shows results of performance tests for the stents crimped using the new crimping method (Lot B) compared to the control group (Lot A). The data presented in this table show that the new crimping method does not produce any adverse effects on retention or slip resistance, recoil, radial strength and modulus of the stents as compared to the control group. The stent retention test was evaluated by a dislodgement test. Two out of the five of stents crimped using the new crimping method were found to have a much higher holding force.
TABLE 3 |
Recoil, retention, radial strength and modulus of stents |
# of | # of | ||||||
Test | samples | Average | STD Dev | Test | samples | Average | STD Dev |
Recoil | 5 | 8.6% | 2.1% | Recoil | 5 | 7.9% | 1.5% |
% Length | 3.9% | 2.7% | % Length | 2.6% | 0.8% | ||
Change | Change | ||||||
Uniformity | 0.04 | 0.03 | Uniformity | 0.06 | 0.01 | ||
of Expansion | of Expansion | ||||||
Radial | 5 | 7.978 | 0.290 | Radial | 5 | 7.726 | 0.315 |
Strength | Strength | ||||||
Modulus | 657.7 | 105.246 | Modulus | 677.9 | 85.334 | ||
Dislodgement | 5 | 1.2566 | 0.192361119 | Dislodgement | 5 | 1.2834 | 0.085909 |
test | test | ||||||
Claims (17)
1. A method for making a medical device, comprising:
providing a balloon having a shape memory forming prearranged pleats or wings, wherein the prearranged pleats or wings have kinks;
working-out the shape memory including removing the kink of at least one of the prearranged pleats or wings, thereby replacing the at least one of the prearranged pleats or wings with random folds; and
crimping a stent including plastically deforming the stent onto the balloon while the balloon has the random folds.
2. The method of
claim 1, wherein the stent comprises a polymer having a glass transition temperature of between 40 and 60 degrees Celsius.
3. The method of
claim 1, wherein the working-out the shape memory includes removing at least one heat set pleat or wing that is folded in a spiral or accordion-like fashion.
4. The method of
claim 3, wherein the balloon shape memory is worked-out by inflating and deflating the balloon or applying a fluid to a surface of the balloon.
5. The method of
claim 1, wherein when the stent is crimped to the balloon all of the prearranged pleats or wings are replaced by random folds.
6. The method of
claim 1,
wherein the balloon is a 3.0 mm balloon; and
wherein the crimped stent has an outer diameter of 0.053 inches.
7. The method of
claim 1, wherein the balloon is a non-compliant or semi-compliant balloon.
8. The method of
claim 1, wherein a membrane of the worked-out balloon is folded over itself in an irregular manner when the stent has a final crimping diameter.
9. The method of
claim 1, wherein the stent is crimped to the balloon using an iris-type crimping mechanism.
10. (A method for making a medical device, comprising:
providing a balloon having a shape memory forming prearranged folds;
working-out the shape memory, whereby at least one of the prearranged folds is replaced by random folds;
placing a stent over the balloon after working out the shape memory, wherein the balloon is at least partially inflated when the stent is placed over the balloon; and
crimping the stent including plastically deforming the stent onto the balloon while the balloon has the random folds.
11. The method of
claim 10, wherein the balloon is inflated such that the stent is snugly fit over the inflated balloon when the stent is placed over the inflated balloon.
12. The method of
claim 10, wherein the balloon is inflated such that the stent is loosely fit over the inflated balloon when the stent is placed over the inflated balloon.
13. The method of
claim 1, wherein the working out the shape memory includes inflating and deflating the balloon several times.
14. The method of
claim 1, wherein the crimping step includes using an iris crimper to plastically deform the stent onto the balloon, wherein the iris crimper applies a continuous crimping force until the stent reaches a final crimp diameter.
15. The method of
claim 1, wherein the crimping step includes using an iris crimper to plastically deform the stent onto the balloon, wherein the iris crimper applies a crimping force in an intermittent step-wise fashion until the stent reaches a final crimp diameter.
16. The method of
claim 1, wherein the stent is a laser cut polymeric stent made from a material including poly (L-lactide).
17. A method for making a medical device, comprising:
providing a balloon having a shape memory forming prearranged pleats or wings, wherein the prearranged pleats or wings have kinks;
working-out the shape memory by increasing a pressure until the balloon is inflated, wherein when the balloon is inflated all of the kinks are substantially removed, followed by placing the balloon in a relaxed state wherein at least one of the prearranged pleats or wings is replaced by random folds; and
crimping the stent including plastically deforming the stent onto the balloon while the balloon has the relaxed state.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US14/059,382 US9504590B2 (en) | 2007-09-28 | 2013-10-21 | Stent retained on a balloon catheter |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US11/864,834 US8046897B2 (en) | 2007-09-28 | 2007-09-28 | Method and apparatus for stent retention on a balloon catheter |
US13/252,965 US8739384B2 (en) | 2007-09-28 | 2011-10-04 | Method for stent retention on a balloon catheter |
US14/059,382 US9504590B2 (en) | 2007-09-28 | 2013-10-21 | Stent retained on a balloon catheter |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US13/252,965 Division US8739384B2 (en) | 2007-09-28 | 2011-10-04 | Method for stent retention on a balloon catheter |
Publications (2)
Publication Number | Publication Date |
---|---|
US20140052235A1 US20140052235A1 (en) | 2014-02-20 |
US9504590B2 true US9504590B2 (en) | 2016-11-29 |
Family
ID=40243903
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US11/864,834 Active 2029-05-08 US8046897B2 (en) | 2007-09-28 | 2007-09-28 | Method and apparatus for stent retention on a balloon catheter |
US13/252,965 Expired - Fee Related US8739384B2 (en) | 2007-09-28 | 2011-10-04 | Method for stent retention on a balloon catheter |
US14/059,382 Active 2028-04-12 US9504590B2 (en) | 2007-09-28 | 2013-10-21 | Stent retained on a balloon catheter |
Family Applications Before (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US11/864,834 Active 2029-05-08 US8046897B2 (en) | 2007-09-28 | 2007-09-28 | Method and apparatus for stent retention on a balloon catheter |
US13/252,965 Expired - Fee Related US8739384B2 (en) | 2007-09-28 | 2011-10-04 | Method for stent retention on a balloon catheter |
Country Status (4)
Country | Link |
---|---|
US (3) | US8046897B2 (en) |
EP (2) | EP2197393B1 (en) |
JP (2) | JP5469071B2 (en) |
WO (1) | WO2009045764A1 (en) |
Families Citing this family (41)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8597716B2 (en) * | 2009-06-23 | 2013-12-03 | Abbott Cardiovascular Systems Inc. | Methods to increase fracture resistance of a drug-eluting medical device |
US7886419B2 (en) * | 2006-07-18 | 2011-02-15 | Advanced Cardiovascular Systems, Inc. | Stent crimping apparatus and method |
WO2008034048A2 (en) * | 2006-09-15 | 2008-03-20 | Boston Scientific Limited | Bioerodible endoprosthesis with biostable inorganic layers |
US20080249605A1 (en) * | 2007-04-04 | 2008-10-09 | Vipul Dave | Bioabsorbable Polymer, Non-Bioabsorbable Metal Composite Stents |
US8046897B2 (en) | 2007-09-28 | 2011-11-01 | Abbott Cardiovascular Systems Inc. | Method and apparatus for stent retention on a balloon catheter |
US20090163985A1 (en) * | 2007-12-19 | 2009-06-25 | Vipul Dave | Method of Retaining a Polymeric Stent on an Expansion Member |
EP2095795A1 (en) * | 2007-12-21 | 2009-09-02 | Abbott Laboratories Vascular Enterprises Limited | Double layered balloons in medical devices |
DE102008006092A1 (en) * | 2008-01-25 | 2009-07-30 | Biotronik Vi Patent Ag | Multiple membrane balloon and method of making a multiple membrane balloon |
WO2010138411A1 (en) * | 2009-05-26 | 2010-12-02 | Cook Incorporated | Two-stage method of compressing a stent |
JP5947716B2 (en) * | 2010-03-30 | 2016-07-06 | テルモ株式会社 | Manufacturing method of stent delivery system |
US8844113B2 (en) | 2010-04-30 | 2014-09-30 | Abbott Cardiovascular Systems, Inc. | Methods for crimping a polymeric stent scaffold onto a delivery balloon |
US8261423B2 (en) | 2010-04-30 | 2012-09-11 | Abbott Cardiovascular Systems Inc. | Methods for crimping a polymeric stent onto a delivery balloon |
US8752261B2 (en) * | 2010-07-07 | 2014-06-17 | Abbott Cardiovascular Systems Inc. | Mounting stents on stent delivery systems |
US8539663B2 (en) | 2010-08-23 | 2013-09-24 | Abbott Cardiovascular Systems Inc. | Reducing crimping damage to polymer scaffold |
US8595913B2 (en) * | 2010-09-30 | 2013-12-03 | Advanced Cardiovascular Systems, Inc. | Stent crimping methods |
US9056025B2 (en) * | 2010-12-15 | 2015-06-16 | Svelte Medical Systems, Inc. | Means and method for preventing embolization of drug eluting stents |
US11484318B2 (en) | 2011-01-17 | 2022-11-01 | Artio Medical, Inc. | Expandable body device and method of use |
ES2676661T3 (en) * | 2011-01-17 | 2018-07-23 | Metactive Medical, Inc. | Sphere Stent Device |
WO2013109309A1 (en) | 2012-01-17 | 2013-07-25 | Novita Therapeutics, Llc | Expandable body device and method of use |
US8961848B2 (en) | 2011-04-18 | 2015-02-24 | Abbott Cardiovascular Systems Inc. | Methods for increasing a retention force between a polymeric scaffold and a delivery balloon |
US9199408B2 (en) | 2012-04-03 | 2015-12-01 | Abbott Cardiovascular Systems Inc. | Uniform crimping and deployment methods for polymer scaffold |
JP6078530B2 (en) * | 2011-04-18 | 2017-02-08 | アボット カルディオバスキュラー システムズ インコーポレーテッドAbbott Cardiovascular Systems Inc. | Uniform crimping and deployment method for polymer scaffolds |
US20120290063A1 (en) | 2011-05-09 | 2012-11-15 | Abbott Cardiovascular Systems Inc. | Method of Increasing Stent Retention of Bioabsorbable Scaffolding with a Sheath |
US8752265B2 (en) | 2011-05-13 | 2014-06-17 | Abbott Cardiovascular Systems Inc. | Methods for crimping a polymeric scaffold to a delivery balloon and achieving stable mechanical properties in the scaffold after crimping |
US8414528B2 (en) | 2011-05-27 | 2013-04-09 | Abbott Cardiovascular Systems Inc. | Polymer scaffold sheaths |
US8726483B2 (en) * | 2011-07-29 | 2014-05-20 | Abbott Cardiovascular Systems Inc. | Methods for uniform crimping and deployment of a polymer scaffold |
US9254212B2 (en) * | 2012-04-06 | 2016-02-09 | Abbott Cardiovascular Systems Inc. | Segmented scaffolds and delivery thereof for peripheral applications |
US9283100B2 (en) | 2012-05-16 | 2016-03-15 | Abbott Cardiovascular Systems Inc. | Polymer scaffold with multi-pleated balloon |
JP6026776B2 (en) * | 2012-05-25 | 2016-11-16 | 株式会社グッドマン | Stent delivery catheter manufacturing method and stent attachment device |
US9724219B2 (en) * | 2012-10-04 | 2017-08-08 | Abbott Cardiovascular Systems Inc. | Method of uniform crimping and expansion of medical devices |
US9440317B2 (en) * | 2013-01-07 | 2016-09-13 | Abbott Cardiovascular Systems Inc. | Post-crimping inspection of scaffolds mounted on scaffold delivery systems |
US9125763B2 (en) * | 2013-03-15 | 2015-09-08 | Abbott Cardiovascular Systems Inc. | Stent crimping tool insert, system, and method |
US10092723B2 (en) * | 2013-05-07 | 2018-10-09 | Lamina Solutions Llc | Retention drainage catheter |
US10092724B2 (en) | 2013-05-07 | 2018-10-09 | Lamina Solutions Llc | Retention drainage catheter |
BR112017005170B1 (en) | 2014-09-17 | 2022-10-11 | Artio Medical, Inc | MEDICAL SYSTEM |
EP3231400B1 (en) * | 2014-12-08 | 2020-09-30 | Dotter Inc. | Biodegradable stent and shape memory expanding method therefor |
JPWO2016104017A1 (en) * | 2014-12-26 | 2017-10-05 | テルモ株式会社 | Stent and method for manufacturing stent |
US10010653B2 (en) * | 2016-02-05 | 2018-07-03 | Abbott Cardiovascular Systems Inc. | Methods for increasing coating strength to improve scaffold crimping yield |
US10660773B2 (en) | 2017-02-14 | 2020-05-26 | Abbott Cardiovascular Systems Inc. | Crimping methods for thin-walled scaffolds |
US10555825B2 (en) | 2017-11-09 | 2020-02-11 | Abbott Cardiovascular Systems Inc. | Rotation of a medical device during crimping |
US10967556B2 (en) | 2018-06-11 | 2021-04-06 | Abbott Cardiovascular Systems Inc. | Uniform expansion of thin-walled scaffolds |
Citations (33)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4733665A (en) | 1985-11-07 | 1988-03-29 | Expandable Grafts Partnership | Expandable intraluminal graft, and method and apparatus for implanting an expandable intraluminal graft |
US4800882A (en) | 1987-03-13 | 1989-01-31 | Cook Incorporated | Endovascular stent and delivery system |
US4886062A (en) | 1987-10-19 | 1989-12-12 | Medtronic, Inc. | Intravascular radially expandable stent and method of implant |
US5507768A (en) | 1991-01-28 | 1996-04-16 | Advanced Cardiovascular Systems, Inc. | Stent delivery system |
US5514154A (en) | 1991-10-28 | 1996-05-07 | Advanced Cardiovascular Systems, Inc. | Expandable stents |
US5556383A (en) | 1994-03-02 | 1996-09-17 | Scimed Lifesystems, Inc. | Block copolymer elastomer catheter balloons |
US5569295A (en) | 1993-12-28 | 1996-10-29 | Advanced Cardiovascular Systems, Inc. | Expandable stents and method for making same |
US5836965A (en) | 1994-10-19 | 1998-11-17 | Jendersee; Brad | Stent delivery and deployment method |
US5913871A (en) | 1996-09-25 | 1999-06-22 | Medtronic, Inc. | Balloon modification for improved stent fixation and deployment |
US5976181A (en) | 1997-09-22 | 1999-11-02 | Ave Connaught | Balloon mounted stent and method therefor |
WO1999055406A1 (en) | 1998-04-27 | 1999-11-04 | Advanced Cardiovascular Systems, Inc. | Catheter balloon with biased multiple wings |
US20020143382A1 (en) | 2001-03-29 | 2002-10-03 | Luuk Hijlkema | Thermal regulation of a coated work-piece during the reconfiguration of the coated work-piece |
US6488688B2 (en) | 1998-04-21 | 2002-12-03 | Advanced Cardiovascular Systems, Inc. | Stent deploying catheter system and balloon catheter |
EP1295570A2 (en) | 2001-09-19 | 2003-03-26 | JOMED GmbH | Cold-molding process for loading a stent onto a stent delivery system |
US6629350B2 (en) | 2000-06-08 | 2003-10-07 | Tom Motsenbocker | Stent crimping apparatus and method |
US20040078953A1 (en) | 2002-10-29 | 2004-04-29 | Spilka David G | Stent compression method |
US20040106973A1 (en) | 2001-02-16 | 2004-06-03 | Johnson Eric G | Balloon catheter stent delivery system with ridges |
JP2004527285A (en) | 2001-02-16 | 2004-09-09 | コーディス・コーポレイション | Balloon catheter stent delivery system with ridge |
US20050119720A1 (en) | 2003-12-01 | 2005-06-02 | Advanced Cardiovascular Systems, Inc. State Of Incorporation: California | Temperature controlled crimping |
US20050244533A1 (en) | 2001-03-26 | 2005-11-03 | Tom Motsenbocker | Balloon folding technology |
US20060047336A1 (en) | 2004-08-25 | 2006-03-02 | Gale David C | Stent-catheter assembly with a releasable connection for stent retention |
WO2006117016A1 (en) | 2005-04-29 | 2006-11-09 | Arterial Remodelling Technologies, Inc. | Stent crimping |
US20070271763A1 (en) | 2006-05-25 | 2007-11-29 | Bin Huang | Method of crimping a polymeric stent |
US20070282433A1 (en) | 2006-06-01 | 2007-12-06 | Limon Timothy A | Stent with retention protrusions formed during crimping |
US20070289117A1 (en) | 2006-06-19 | 2007-12-20 | Bin Huang | Methods for improving stent retention on a balloon catheter |
US7316148B2 (en) | 2005-02-15 | 2008-01-08 | Boston Scientific Scimed, Inc. | Protective sheet loader |
US20080016668A1 (en) | 2006-07-18 | 2008-01-24 | Bin Huang | Stent crimping apparatus and method |
US20080033523A1 (en) | 2006-07-10 | 2008-02-07 | Gale David C | Stent crack reduction |
US20080033524A1 (en) | 2006-07-11 | 2008-02-07 | Gale David C | Heated balloon assembly for delivery of polymeric stents |
US20080147164A1 (en) | 2006-12-13 | 2008-06-19 | Gale David C | Optimizing fracture toughness of polymeric stent |
US7951185B1 (en) | 2006-01-06 | 2011-05-31 | Advanced Cardiovascular Systems, Inc. | Delivery of a stent at an elevated temperature |
US8046897B2 (en) | 2007-09-28 | 2011-11-01 | Abbott Cardiovascular Systems Inc. | Method and apparatus for stent retention on a balloon catheter |
US8123793B2 (en) | 2008-09-10 | 2012-02-28 | Boston Scientific Scimed, Inc. | Pre-crimp balloon inflation |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0898892A (en) * | 1994-09-29 | 1996-04-16 | Terumo Corp | Expansion catheter and its production |
JP2005074154A (en) * | 2003-09-03 | 2005-03-24 | Terumo Corp | Indwelling prosthesis assembly and manufacturing method thereof |
US7597702B2 (en) * | 2003-09-17 | 2009-10-06 | Boston Scientific Scimed, Inc. | Balloon assembly with a torque |
-
2007
- 2007-09-28 US US11/864,834 patent/US8046897B2/en active Active
-
2008
- 2008-09-19 JP JP2010527057A patent/JP5469071B2/en not_active Expired - Fee Related
- 2008-09-19 WO PCT/US2008/077108 patent/WO2009045764A1/en active Application Filing
- 2008-09-19 EP EP08836276.9A patent/EP2197393B1/en not_active Not-in-force
- 2008-09-19 EP EP17150700.7A patent/EP3184086A1/en not_active Withdrawn
-
2011
- 2011-10-04 US US13/252,965 patent/US8739384B2/en not_active Expired - Fee Related
-
2013
- 2013-10-21 US US14/059,382 patent/US9504590B2/en active Active
-
2014
- 2014-01-28 JP JP2014013115A patent/JP5941933B2/en not_active Expired - Fee Related
Patent Citations (40)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4733665C2 (en) | 1985-11-07 | 2002-01-29 | Expandable Grafts Partnership | Expandable intraluminal graft and method and apparatus for implanting an expandable intraluminal graft |
US4733665B1 (en) | 1985-11-07 | 1994-01-11 | Expandable Grafts Partnership | Expandable intraluminal graft,and method and apparatus for implanting an expandable intraluminal graft |
US4733665A (en) | 1985-11-07 | 1988-03-29 | Expandable Grafts Partnership | Expandable intraluminal graft, and method and apparatus for implanting an expandable intraluminal graft |
US4800882A (en) | 1987-03-13 | 1989-01-31 | Cook Incorporated | Endovascular stent and delivery system |
US4886062A (en) | 1987-10-19 | 1989-12-12 | Medtronic, Inc. | Intravascular radially expandable stent and method of implant |
US5507768A (en) | 1991-01-28 | 1996-04-16 | Advanced Cardiovascular Systems, Inc. | Stent delivery system |
US5514154A (en) | 1991-10-28 | 1996-05-07 | Advanced Cardiovascular Systems, Inc. | Expandable stents |
US5569295A (en) | 1993-12-28 | 1996-10-29 | Advanced Cardiovascular Systems, Inc. | Expandable stents and method for making same |
US5556383A (en) | 1994-03-02 | 1996-09-17 | Scimed Lifesystems, Inc. | Block copolymer elastomer catheter balloons |
US5836965A (en) | 1994-10-19 | 1998-11-17 | Jendersee; Brad | Stent delivery and deployment method |
US5913871A (en) | 1996-09-25 | 1999-06-22 | Medtronic, Inc. | Balloon modification for improved stent fixation and deployment |
US5976181A (en) | 1997-09-22 | 1999-11-02 | Ave Connaught | Balloon mounted stent and method therefor |
US6488688B2 (en) | 1998-04-21 | 2002-12-03 | Advanced Cardiovascular Systems, Inc. | Stent deploying catheter system and balloon catheter |
WO1999055406A1 (en) | 1998-04-27 | 1999-11-04 | Advanced Cardiovascular Systems, Inc. | Catheter balloon with biased multiple wings |
US6629350B2 (en) | 2000-06-08 | 2003-10-07 | Tom Motsenbocker | Stent crimping apparatus and method |
JP2004527285A (en) | 2001-02-16 | 2004-09-09 | コーディス・コーポレイション | Balloon catheter stent delivery system with ridge |
US20040106973A1 (en) | 2001-02-16 | 2004-06-03 | Johnson Eric G | Balloon catheter stent delivery system with ridges |
US20050244533A1 (en) | 2001-03-26 | 2005-11-03 | Tom Motsenbocker | Balloon folding technology |
US7010850B2 (en) | 2001-03-29 | 2006-03-14 | Boston Scientific Scimed, Inc. | Thermal regulation of a coated work-piece during the reconfiguration of the coated work-piece |
US20020143382A1 (en) | 2001-03-29 | 2002-10-03 | Luuk Hijlkema | Thermal regulation of a coated work-piece during the reconfiguration of the coated work-piece |
US6863683B2 (en) | 2001-09-19 | 2005-03-08 | Abbott Laboratoris Vascular Entities Limited | Cold-molding process for loading a stent onto a stent delivery system |
EP1295570A2 (en) | 2001-09-19 | 2003-03-26 | JOMED GmbH | Cold-molding process for loading a stent onto a stent delivery system |
US20050143752A1 (en) | 2001-09-19 | 2005-06-30 | Abbott Laboratories Vascular Entities Limited | Cold-molding process for loading a stent onto a stent delivery system |
US20040078953A1 (en) | 2002-10-29 | 2004-04-29 | Spilka David G | Stent compression method |
US6745445B2 (en) | 2002-10-29 | 2004-06-08 | Bard Peripheral Vascular, Inc. | Stent compression method |
US20050119720A1 (en) | 2003-12-01 | 2005-06-02 | Advanced Cardiovascular Systems, Inc. State Of Incorporation: California | Temperature controlled crimping |
US20060047336A1 (en) | 2004-08-25 | 2006-03-02 | Gale David C | Stent-catheter assembly with a releasable connection for stent retention |
US7316148B2 (en) | 2005-02-15 | 2008-01-08 | Boston Scientific Scimed, Inc. | Protective sheet loader |
WO2006117016A1 (en) | 2005-04-29 | 2006-11-09 | Arterial Remodelling Technologies, Inc. | Stent crimping |
US7951185B1 (en) | 2006-01-06 | 2011-05-31 | Advanced Cardiovascular Systems, Inc. | Delivery of a stent at an elevated temperature |
US20070271763A1 (en) | 2006-05-25 | 2007-11-29 | Bin Huang | Method of crimping a polymeric stent |
US7761968B2 (en) | 2006-05-25 | 2010-07-27 | Advanced Cardiovascular Systems, Inc. | Method of crimping a polymeric stent |
US20070282433A1 (en) | 2006-06-01 | 2007-12-06 | Limon Timothy A | Stent with retention protrusions formed during crimping |
US20070289117A1 (en) | 2006-06-19 | 2007-12-20 | Bin Huang | Methods for improving stent retention on a balloon catheter |
US20080033523A1 (en) | 2006-07-10 | 2008-02-07 | Gale David C | Stent crack reduction |
US20080033524A1 (en) | 2006-07-11 | 2008-02-07 | Gale David C | Heated balloon assembly for delivery of polymeric stents |
US20080016668A1 (en) | 2006-07-18 | 2008-01-24 | Bin Huang | Stent crimping apparatus and method |
US20080147164A1 (en) | 2006-12-13 | 2008-06-19 | Gale David C | Optimizing fracture toughness of polymeric stent |
US8046897B2 (en) | 2007-09-28 | 2011-11-01 | Abbott Cardiovascular Systems Inc. | Method and apparatus for stent retention on a balloon catheter |
US8123793B2 (en) | 2008-09-10 | 2012-02-28 | Boston Scientific Scimed, Inc. | Pre-crimp balloon inflation |
Non-Patent Citations (2)
Title |
---|
International Search Report and the Written Opinion for PCT/US2008/077108 mailed Feb. 2, 2009, 6 pgs. |
U.S. Appl. No. 11/330,927, filed Jan. 11, 2006, Wu et al. |
Also Published As
Publication number | Publication date |
---|---|
US20120017416A1 (en) | 2012-01-26 |
US8046897B2 (en) | 2011-11-01 |
US20140052235A1 (en) | 2014-02-20 |
JP2010540091A (en) | 2010-12-24 |
JP2014111157A (en) | 2014-06-19 |
US20090088829A1 (en) | 2009-04-02 |
EP2197393A1 (en) | 2010-06-23 |
EP3184086A1 (en) | 2017-06-28 |
EP2197393B1 (en) | 2017-01-11 |
WO2009045764A1 (en) | 2009-04-09 |
JP5469071B2 (en) | 2014-04-09 |
US8739384B2 (en) | 2014-06-03 |
JP5941933B2 (en) | 2016-06-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US9504590B2 (en) | 2016-11-29 | Stent retained on a balloon catheter |
US10342688B2 (en) | 2019-07-09 | Methods for improving stent retention on a balloon catheter |
US7886419B2 (en) | 2011-02-15 | Stent crimping apparatus and method |
US8062465B1 (en) | 2011-11-22 | Methods for improved stent retention |
AU2013336675B2 (en) | 2017-10-26 | Crimping method for bioresorbable stents |
US10660773B2 (en) | 2020-05-26 | Crimping methods for thin-walled scaffolds |
US10967556B2 (en) | 2021-04-06 | Uniform expansion of thin-walled scaffolds |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
2016-11-09 | STCF | Information on status: patent grant |
Free format text: PATENTED CASE |
2020-04-15 | MAFP | Maintenance fee payment |
Free format text: PAYMENT OF MAINTENANCE FEE, 4TH YEAR, LARGE ENTITY (ORIGINAL EVENT CODE: M1551); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY Year of fee payment: 4 |
2024-06-13 | FEPP | Fee payment procedure |
Free format text: 7.5 YR SURCHARGE - LATE PMT W/IN 6 MO, LARGE ENTITY (ORIGINAL EVENT CODE: M1555); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY |
2024-06-13 | MAFP | Maintenance fee payment |
Free format text: PAYMENT OF MAINTENANCE FEE, 8TH YEAR, LARGE ENTITY (ORIGINAL EVENT CODE: M1552); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY Year of fee payment: 8 |